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Abstract
When estimating the influence income per capita exerts on health care expenditure, the re-
search in the field offers mixed results. Studies employ different data, estimation techniques
and models, which brings about the question whether these differences in research design play
any part in explaining the heterogeneity of reported outcomes. By employing meta-regression
analysis, the present paper analyzes 220 estimates of health spending income elasticity collected
from 54 studies and finds that publication bias is of marginal concern for the literature. The
model specification choices, more exactly whether a study accounts for institutional factors and
advancements in medical technology, have a negative effect on reported outcomes. Moreover,
the “economic research cycle hypothesis” finds support in our analysis. Lastly, the research finds
that the true income elasticity of health spending is situated around unity level, which makes
health care neither a luxury, nor a necessity.
Abstrakt
Tato práce analyzuje vliv národńıho bohatstv́ı (výše HDP per capita) na výdaje ve zdravotnictv́ı.
Existuj́ıćı výzkumné studie, které přináši nejednoznačné výsledky, použ́ıvaj́ı ru̇zná data, metody
odhadu a modely, což navozuje otázku, zda tyto metodologické rozdily hraj́ı du̇ležitou roli při
vysvétlováńı ru̇znorodosti vykazovaných výsledku̇. Tato práce zkoumá za použiti meta-regresńı
analýzy 220 odhadu̇ du̇chodové elasticity výdaju̇ na zdravotnictv́ı shromáždéných v 54 studiich,
a zjíst’uje, že literatura na toto téma netrṕı vyznamným zkresleńım. Specifikace modelu, přesněji
řečeno, zda studie bere v úvahu institucionálńı faktory a pokrok v lékařské technologii, má neg-
ativńı vliv na výsledky publikované v daľśıch studiich. Kromě toho se analýza oṕırá o hypotézu
”cyklu economického vyzkumu”. V neposledńı řadě analýza zjǐst’uje, že skutečná du̇chodová
elasticita výdaju̇ na zdravotnictv́ı se pohybuje okolo úrovně 1, což znamená, že zdravotńı péče
neni ani luxusńı, ani nezbytnou komoditou.
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Is health care a luxury or a necessity good? Does the literature analyzing
the effect of per capita income on aggregate health care spending suffer
from publication bias? Does the ”economic cycle research hypothesis”
apply to the studies researching the relation between per capita income
and aggregate health care expenditure?
Brief descrip-
tion of theory
The theory of MRA is steadily grounded in statistical theory. Since
MRA analyzes estimates generated by prior research, these estimates
had already been previously tested and all needed assumption related
to the underlying economic relationship had already been made in the
primary research. The statistical theory states that the estimated regres-
sion coefficients of the primary studies, which become the MRA depen-
dent variable, should be asymptotically normal with estimated variance
equal to the squared value of its standard error. In case of publication
bias, the MRA dependent variable will be correlated to its standard
errors and the funnel graph of the collected estimated regression coeffi-
cients against their precision will be asymmetrical. When asymmetry is
noted, then the reported estimates are heterogenous and the explanation




The observations of the meta-data are collected from all reported out-
comes of the studies which analyze the relation between income per
capita and health expenditure. Characteristics of the primary stud-
ies,i.e the estimation technique employed, the type of data used, the
publication year of the paper, the explanatory variables included in their
regression model, type of robustness tests performed, become the meta-
independent variables, which are expected to explain the heterogeneity
in reported outcomes of primary studies.
Conclusion Publication bias is of marginal concern for the literature, while
the“economics research cycle hypothesis” is confirmed. The heterogene-
ity in reported income elasticities of health expenditure can be explained
by a number of study design characteristics. Whether a study accounts
for institutional factors and progress in medical technology has a neg-
ative effect on reported outcomes. The true income elasticity of health
spending is situated around unity level, which makes health care neither
a luxury, nor a necessity.
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“Where is the knowledge
we have lost in information?” (Eliot T.S. 1971)
“ . . . only by conducting a meta-analysis can you appreciate
how messy the literature is, how inconsistent researchers are
in how they measure, analyze data . . . and just where is the
work to be done.” (Hayes in Allen 2009)
Introduction
The relation between per capita income and health care costs has drawn a considerable
amount of attention in the last decades. The beginning of research into this matter,
marked by the study published in 1977 by Newhouse, found that the income elasticity of
health care costs stands above unity, placing health care in the luxury good category. As
methods of research developed and more data became available, upcoming studies, e.g.
O’ Connell (1996), became skeptical of the luxury good hypothesis and made claims,
supported by empirical research, that health care is in fact a necessity, and its income
elasticity lies below unity. Some possible influencing factors for the differences in out-
comes were offered, ranging from the level of aggregation of data (regional, country-level
or international), which might introduce in the analysis the problem of heterogeneity
among different health care systems (Gertham 1992), the methodology employed and
the number of robustness checks performed (Roberts 2000) or the independent variables
included in the research model (Gerdtham & Jönsson 2000). The importance of placing
health care in the appropriate category of goods lies in its social implications. If health
care is a necessity, then more public involvement will be required for its equal provision
to all citizens. Thus, public spending will represent a higher proportion in total health
care expenditure. When health care lies in the luxury good category, it is thought that
its provision would be better left to market forces and, therefore, the share of private
spending in total health care expenditure would increase. Nevertheless, due to the lack
of a sound theory on health expenditure determinants and the methodological complex-
ities which developed in time, drawing a general conclusion from all existing studies
becomes a difficult task.
The objectives of this thesis are manifold. First of all, the present study aims to
reveal the true nature of health care, by pooling the findings of the literature on the
determinants of aggregate health care expenditure. Employing meta-regression analysis,
this thesis also intends to reveal whether components of a study’s design influence
the value of its reported income elasticity of health spending. Uncovering any such
potential drivers of reported outcomes in the literature would not only help explain
the heterogeneity in results, but also offer guidance for further research regarding the
aspects that should be included into one’s study, in order to produce a paper that comes
closer to a “best practice” model. The present research also aims to see whether the
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literature looking at per capita income’s effect on aggregate health care costs suffers
from publication bias, i.e. the preference of referees, publishers (authors) to publish
(report) only results that are significant or which uncover a certain direction of the
relation between income per capita and health spending. Finally, this study also tests
whether the literature follows an “economics research cycle”, i.e a pattern in which
innovative results are preferred for an amount of time, after which empirical evidence
in the opposite direction is given preference (Stanley 2008 in Havránek 2013).
The thesis is structured as follows: chapter 1 summarizes previous findings of health
care spending income elasticity values, alongside differences in papers’ methodology
and possible factors explaining the heterogeneity in outcomes, chapter 2 offers the back-
ground and evolution of the meta-regression analysis technique, chapter 3 and chapter 4
explain the methodology and dataset employed by the present research, chapter 5 illus-
trates the results, while chapter 6 discusses the findings of our study and their possible
implications.
Chapter 1
Empirical literature on drivers of
health care expenditure
1.1 Trends and findings of previous research
Much ink has been spilled over the possible drivers of aggregate health care spend-
ing. The first one to analyze econometrically the relation between income and medical
expenditure was Newhouse (1977). Using cross-sectional data from 13 developed coun-
tries, he revealed that variation in per capita income alone could explain as much as
90 % of variation in a country’s per capita health spending. The income elasticity of
national medical-care expenditure was found to vary from 1.15 to 1.31, making thus
health care a luxury good. After this seminal work, many papers on the topic followed,
being possible to classify them in distinct groups, according to the focus in research.
The initial wave of papers (Leu 1986; Parkin et al., 1984; Milne & Molana 1991;
Gerdtham & Jönsson 1991) focused on testing the findings of Newhouse regarding the
magnitude and sign of per capita income influence on the health expenditure of a state,
using cross-sectional data. These studies provided support for the conclusion reached
by Newhouse: all of them found that income had a significant effect on total health care
expenditure, with elasticity higher than one. Leu (1986) reported an income elasticity
of 1.21, Gerdtham & Jönsson (1991) report a value of 1.43, while the results of Milne &
Molana (1991) pointed to an even higher responsiveness of health expenditure to income
changes of 1.74.
The next wave of research, which started at the beginning of the 1990s, focused on
exploring the wider range of data sets that became available. As a result, a shift from
cross-sectional to time-series and panel data sets occurred, alongside the tendency of
including more explanatory variables in the regression model. Apart from income per
capita, other factors considered to have an influence on total health spending were: the
share of people older than 65 in the total population, the share of public expenditure in
total health expenditure, technological advances, and the institutional characteristics of
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the healthcare system (e.g. physicians working as gatekeepers, level of centralization of
health care system, ways of remunerating physicians). In section 1.2 these additional
explanatory variables will be looked at into more detail.
The use of panel data enabled the inclusion of country and time-effects in the re-
gression model, which made previous findings highly questionable. New results pointed
at income elasticity of health expenditure lower than one (Gerdtham et al. 1998) or
very close to unity (Hitris & Posnett 1992) and the nature of health care as a luxury or
necessary good started to be highly debated. Multivariate regression models displayed
an even lower effect of income per capita on health expenditure, which made clear that
previous research focusing solely on GDP per capita as an explanatory variable suffered
from omitted variables bias. In this new context, Gerdtham et al.(1998) analyzed 20
OECD countries by pooling cross-sections and time-series and reached the conclusion
that the income elasticity of aggregate health spending is 0.74 and thus health care is a
necessity. O’ Connell’s (1996) results were even more radical. With a sample consisting
of 21 OECD countries observed over 25 years, and using GLS estimates, he reported an
income elasticity of health expenditure of merely 0.23.
The third wave of research on the determinants of health care spending focused
mainly on the time-series proprieties of the data and the improvement of the method-
ological process (Blomqvist & Carter 1997; Karatzas 2000; Freeman 2003; Dreger &
Reimers 2005; Lago-Peñas et al. 2013). The stationarity of the random disturbances
of data series, checking for unit roots, cointegration, structural breaks and developing
new, reliable robustness tests became the central point of interest in research.
One of the first papers oriented towards this new approach was Hansen and King
(1996). Replicating Hitris and Posnett’s study (1992), they used the same dataset over
the same period of time, but checking for stationarity in the time series of income (GDP
per capita) and real health care expenditure per capita. Statistical theory states that
results obtained using OLS techniques may be misleading, or even entirely spurious, if
the analyzed variables are not separately, or jointly, stationary. In case the data series
are not stationary, the R2 statistic reports a good fit between variables, when in fact
the relation is spurious. What is more, the t and F statistics’ values increase with the
sample size, providing unreliable results (Phillips 1986). Hansen and King (1996) prove
the variables in their model are not collectively stationary in levels, meaning that the
standard OLS model employed by previous research might have generated untrustworthy
estimates due to a spurious relationship.
In a similar fashion, Roberts (2000) re-examined the data and model used by Hitris
(1997) and proved that his results were seriously biased due to having disregarded the
time-series proprieties of the data. After applying standard unit root procedures and
testing for cointegration, Roberts (2000) found non-stationarity in health expenditure,
income per capita and share of total public expenditure in all analyzed countries, a
finding which was robust to a variety of lag lengths. This discovery transformed Hitris’
results into a product of spurious regression problems and directed even more attention
to the importance of a proper consideration of data’s characteristics.
The number of tests employed for analyzing the stationarity of time series grew from
one paper to another, making the methodology more complex, while the explanatory
variables were again confined in most cases only to per capita income. A number of
studies report the presence of unit roots and find that health expenditure and GDP per
capita are first-order integrated I(1)( Blomqvist & Carter 1997; Herwartz & Theilen
2002; Freeman 2003; Atella & Marini 2006). Other studies find no unit roots in the
data series for health care expenditure and GDP (McCoskey & Selden 1998) or they
do identify unit roots in the data, but fail to find a cointegrating relation between the
variables (eg. Hansen and King 1996). One reason for the difference in results might lie
in the type of tests employed, since for instance, Hansen and King use the Augmented
Dickey Fuller (ADF) test, Atella & Marini use Im et al.’s (1997) test and Blomqvist &
Carter (1997) use the Phillips -Perron (PP) test. In what regards reported results of
income elasticity of health care spending, a general overview of the papers which find
proof of cointegration reveals that in many cases the value of this elasticity lies below
unity: 0.721 (Atella & Marini 2006), 0.817(Freeman 2003 or 0. 437 (Herwartz & Theilen
2002).
1.2 Additional drivers of health care spending
Although for a long time income has been assumed to be the main determinant of health
expenditure, explanations for increasing costs of health care have been searched in other
parts as well.
A major determinant of health care spending mentioned by a number of studies is
the share of older population in total population or the dependency rate1.
Although in many cases the choice of model specifications is rather ad hoc, Hitris
& Posnett (1992) and Gerdtham & Jönsson (1992) offer some theoretical reasons for
considering the proportion of the population older than 65 years. Many papers assume
older people use more health resources than other age-groups and test whether a country
with a large percentage of elderly people will have higher health expenditures. Studies
whose results confirm this hypothesis and find a positive influence of ageing on health
spending are numerous and include Bech et al. 2011, Bilgel & Tran 2011, Gerdtham et
al. 1992, Getzen 1992 and Dreger & Reimers 2005.
In contrast, a negative long-term relationship between health expenditures and age-
ing population was found by Samadi & Rad (2013) for a number of ECO2 countries,
1The dependency rate can refer to share of population older than 65 years in total population or
the sum of share of persons older than 65 years old plus the share of population younger than 15 years
old in total population. It is believed that these two age-groups require more health services, and thus
might incur higher health spending.
2ECO= Economic Cooperation Organization
with an elasticity of −0.62, in support of an optimist hypothesis where a country with
elder population is considered healthy and, in consequence, people consume less costly
healthcare than a country with unhealthy people. Herwartz & Theilen (2010) bring
out an interesting finding, namely that the dynamic relationship between healthcare
expenditure, real GDP per capita and the age structure of the population is not ho-
mogeneous across countries but relies on the age composition of the population itself.
More precisely, the income elasticity is steadily larger in economies with a larger share
of elder population. This proven heterogeneity among countries confirms that finding
a common influence of population ageing on health care expenditure in cross-country
comparisons is rather difficult.
A newer school of thought (Zweifel et al. 1999, Seshamani & Gray 2004, Stearns
& Norton 2004, Werblow et al. 2007) supports the idea that what has a significant
effect on health costs are the last years of life of an individual, and not the demographic
age per se. Using Swiss data for the year 1999, Werblow et al. found that, on the
aggregate level, age had a minor effect on an individual’s health care spending, while
proximity to death was strongly positively related to an individual’s health expenditure.
O’Neill et al. (2000) controlled for time to death and found no age effect on the cost
of general practitioners. Furthermore, Seshamani & Gray (2004) used a longitudinal
hospital dataset from Oxfordshire and by predicting costs with bootstrapped 95 %
confidence intervals, found that age significantly affected hospital quarterly costs, but
the magnitude was small compared to the triple growth of these costs in the last year of
life. These scholars named the importance given to the effects of population ageing on
increasing health expenditure a ’red herring’ and an ’illusion of necessity’ (Evans 1985
in Zweifel 1999) by making it appear that health care costs are inevitable and little
can be done by public or private providers to stop their escalation. In addition, they
bring more evidence in favor of Fries’ (1980) hypothesis of ’compression of morbidity’
in OECD countries, where elder generations are healthier and less infirm and use lower
health expenditures than in previous decades.
A further factor included as a regressor in some models is the share of public spending
in total health care expenditure. The hypothesis that has been most tested is that
there exists a positive relationship between health care spending and public expenditure
(Leu 1986), but once again results are mixed. Reported results of elasticities of total
health expenditure to share of public expenditure range from negative values of -0.524
(Gerdtham et al. 1992) and −0.18 (O’Connell 1996) to positive figures of 0.018 (Lopez-
Casasnovas & Saez 2007) or higher at 0.508 (Atella & Marini 2006).
Advancements in medical technology are also held accountable for influencing aggre-
gate health care costs. While superior technology can enable some medical operations to
be performed faster and more efficiently, most technology in health care focuses rather
on increasing the quality of procedures or decreasing the pain of patients, which not all
the time translates in increased quantity of offered health services. Furthermore, new
medical equipment tends to be greatly more expensive than previous one. Finding an
adequate proxy to account for medical technology progress has proved to be a daunting
task, with some scholars choosing a time index (Gerdtham & Lothgren 2000), the num-
ber of surgical procedures (Weil 1995) or the number of medical equipment. Okunade
& Murthy (2002) proxy technological change in medical care by the changes in R&D
spending specific to health care and identify it as the major factor on the supply-side
that causes real per capita aggregate health costs to rise, with an elasticity of 0.43.
Work still needs to be done on the topic, since all proxies used until now have been
criticized as not being able to adequately capture the effect health care technology has
on health spending.
Other explanatory factors encountered most often in the literature as possible de-
terminants of increasing health care costs include:
• the number of physicians per 1,000 people. Some scholars believe that increasing
the number of doctors will determine an increase in HCE, since physicians’ services
are expensive and do not compensate the gains of being healthy. For example,
Murthy & Okunade (2000) find that when the number of physicians/1000 people
increases by 1%, health care costs increase by 1.8%. The opposite hypothesis
states that having more physicians will lead to having a healthier population that
needs to use less resources e.g Gerdtham et. al 1998 find that when the number of
physicians/ 1000 people increases by 1%, aggregate health expenditure decreases
by 14%.
• share of urban population in total population. Most of the times, this variable
is found to be negatively associated with health care expenditure, e.g in Wang
(2009) the elasticity of HCE to urbanization degree varies from −0.49 to −0.54,
while in Thornton and Rice (2008) the elasticity values are between −0.85 and
−0.42. However, Samadi & Rad (2013) find on a balanced panel data of developing
countries during 1995-2009 that the percentage of urbanization had a positive
relationship with the health expenditures, with an elasticity of 0.742.
• education is found to exert a negative influence on health care costs. Thornton &
Rice (2008) report values of elasticity ranging from −0.563 to −0.43 and Cherni-
chovsky & Markowitz (2004) report that an increase of one in years of schooling
will determine a decrease of per capita health care spending of 189, 6$.
• female labor participation force is associated with a switch between informal and
formal health care and presumed to increase aggregate HE. Pammoli et al. (2012)
report an elasticity of health expenditure to female labor participation ratio of
0.784, significant at 1%; Bech et al. (2009) find a long-term elasticity of 0.0281.
• behavioral variables, i.e alcohol and tobacco consumption, obesity rates, were
found to be positively associated with increase in health care costs. Employing
OLS techniques, Thornton & Rice (2008) report elasticities of 0.093 for alcohol
consumption and 0.046 for tobacco consumption in a cross-section of 50 US states.
• remuneration of physicians. Remuneration of physicians by fee-for-service ways
has been thought to instigate a supply-induced demand, since physicians tend
to prescribe patients more services than needed. After investigating data from 19
OECD countries for the year 1987, Gerdtham et al.(1992) find that countries where
fee-for-service systems exist incur health expenditures higher with 1.144% than in
countries which do not have fee-for-service systems. Remunerating physicians by
way of salaries is associated with lower health care spending.
• institutional variables. Mosca (2007) looks particularly at the effect decentral-
ization of healthcare systems has on health care expenditure in a sample of 20
OECD countries during 1990-2000. He arrives at the conclusion that countries
with a decentralized social health insurance system have had the highest health
expenditures, while national health systems were allocating resources more effi-
ciently, but not as efficient as countries with a centralized social insurance system.
Other supposed determinants of aggregate health care expenditure were tested in the
literature, but will not be discussed here, since in most cases they were found insignif-
icant. Although not directly examined by our research, some of the additional drivers
of health care expenditure introduced above will be taken into account as a measure of
explaining the heterogeneity in income elasticities of HE reported by the literature, as
will further be seen in section 4.3.
1.3 Possible determinants of heterogeneity in outcomes
Summing up the literature on the determinants of health care expenditure, it could
be said that little consensus has been reached until now. The only robust finding is
the significant positive influence of per capita GDP (or national income) on per capita
aggregate health expenditure. However, in what concerns the income elasticity of health
spending, opinions are mixed. The same is valid for other potential factors influencing
the level of health care expenditure, as could be seen in the previous section.
Various scholars researching the determinants of aggregate health spending sug-
gested some tracks for justifying the variance in results. One specific area of concern is
represented by the international comparison of health care spending, and more specif-
ically the conversion factors used when translating the income and health expenditure
levels of the countries considered into a common metric which allows comparative re-
search. The two methods having been used until now in the literature are exchange
rates and purchasing power parities (PPP) and certain scholars show differences in re-
ported estimates when the two different conversion methods are used (Parkin et al.
1984). Exchange rates reflect the equalization of prices of internationally traded goods,
but cannot measure adequately the prices of non-tradable goods, such as health care.
Furthermore, the exchange rate regimes alter the fraction of domestic over international
prices and the measurement of prices between depreciating and appreciating countries.
Using PPP over exchange rates presents some advantages, since they are calculated
based on a basket of goods present in all countries. However, this does not account for
the differences in the composition of the basket of goods or to the value the residents
of each country attribute to its components.
Furthermore, one of the major shortcomings of the econometric research of deter-
minants of health expenditure is the absence of a formal economic theory on the topic
(Wilson 1999, p.3). As Roberts (1999) rightly points out, when results of a model are
sensitive to model specification and sample composition, it calls even more for a stronger
theoretical base, against which the model performance can be judged. Otherwise, vari-
ables will continue to be picked ad hoc and results will be as diverse as before. As
Culyer (1989, p.6) puts it: ”theory without history can be as misleading as evidence
without theory”.
A first step towards finding a proper theoretical foundation was done by Hartwig
(2008, 2011), who refers to Baumol’s model of unbalanced growth. This theory suggests
that growth in health care expenditure levels is driven in a directly proportional way
by wage increases in excess of labor productivity growth 3. In his 2008 paper, Hartwig
tests whether empirical results would be in line with this theory. He regresses the
growth of per capita total current health expenditure on the difference between growth
of nominal wages per employee and productivity (labeled ’Baumol variable’) for a data
set comprising 19 OECD countries. The regression model renders a significant value
for Baumol’s variable coefficient of about 1.020 and is able to explain approximately
75% of the variation of health expenditure, even after a battery of robustness checks
is applied, such as including GDP per capita as an additional explanatory variable or
breaking the time-series into three random sub-periods. Furthermore, in a following
study, Hartwig (2011) tests another implication of Baumol’s theory, this time checking
if the variations in the growth rate of relative price of medical care cause variations in
the health expenditure growth rate in the same direction. His findings show a positive
and significant influence of the explanatory variable on health care expenditure growth,
proving more support for the theory.
3Baumol (1967) divides the economy into two sectors, a ”progressive” and a ”non-progressive” one,
assuming that regular growth in labor productivity, which produces new capital goods as a result of
technological innovation, can emerge exclusively in the ”progressive” sector. Health care, along educa-
tion and other services are considered to be part of the non-progressive economic sector that produces
necessities, being high-labor intensive and less physical capital-intensive. Manufacturing industries, on
the other side, are part of the ”progressive” sector. He also assumes that nominal wages in both sectors
are connected in the long run and grow to the same rate as labor productivity in the ”progressive” sector.
Thus, while prices in the ”progressive” sector are stable, those in the ”non-progressive” sector rise so as
to maintain the level of real wages in line with the productivity level. However, if the ”non-progressive”
sector produces necessities, such as health, for which the price elasticity is low, then a larger share of
labor-force will have to move to this sector and, in consequence, a larger share of nominal GDP will
have to be allocated to the sector.
Nevertheless, Hartwig’s track has not been followed by more recent studies. Rather
than considering Baumol’s theory, latest studies (Ang 2010, Bech et al. 2011, Lago-
Peñas et al. 2013, Mehrara et al. 2012 ) still use the classical variables such as income
per capita, share of population older than 65 or institutional variables when trying
to identify the influential factors of total health expenditure. In a certain degree, it
seems understandable, since the perspective offered by Baumol’s theory in the field of
health care is not bright: if indeed health expenditure is bound to rise due to the ”non-
progressive” nature of the health care sector, then little can be done by governments
and policy makers in order to stop this spending from growing.
Reported results have also been considered to vary depending on the level of aggre-
gation of the analysis. Getzen (2000) observed that ”health care is an individual good
and a national luxury” and cannot be labeled strictly as one, since income elasticity
seems to vary with level of analysis. After reviewing results reached in the literature, he
notices that estimates using micro, i.e individual, data tend to find income elasticities
of health expenditure lower than unity, and as the level of aggregation grows at macro
size, so does the income elasticity of health expenditure, an observation also noticed by
Pammoli et al. (1987). A possible explanation is that a person inside a large insured
group may have little incentive to control his health expenditures, while when consid-
ered individually, the health expenditure of a household and its members depends in
many cases on the available financial resources, and not on its health needs.
The structure of data, i.e. cross-sectional, time-series or panel data, has also been
suspected to influence estimates. Pooled time-series allow the introduction of country-
specific and time effects, which control for heterogeneity in institutional variables and
technological advancements of countries being analyzed. It has been observed that,
generally, research using panel data provides lower income elasticities of health expen-
diture than cross-sectional data does, supporting the idea that between group variation
is responsible for part of the magnitude of these elasticities (Freeman 2003, p.495).
Last, but not least, the tests performed on the data and the estimation technique
used might also influence results. When undergoing international comparisons, it is
extremely important to tests for heteroskedasticity, since in most cases the differences in
variables of the countries under observation do not respect the homogeneity assumption
of the CLRM, as Murthy (1991) points out. The problem of possible outliers in samples
consisting of different countries is discussed by Gerdtham & Jönsson (1992), while they
show the change in results occurred by different methods of tackling the issue, i.e.
eliminating outliers from the sample, creating a dummy variable accounting for outliers.
Newer contribution to the topic, such as Okunade et al.(2004), Dormont et al. (2006),
Barros (1998) look at health care expenditure growth rates, instead of levels.
In addition, a plethora of estimation techniques have been used when analyzing the
drivers of aggregate health care spending, from simple OLS to least absolute error (LAE)
in Murthy (1991), GLS in Atella & Marini (2006), WLS in Gbesemete & Gerdtham
(1992), fully modified OLS (FMOLS), dynamic OLS estimators in Freeman (2003) and
many others. The same bewildering number characterizes the tests performed on the
data, which makes one think these differences in methodology and estimation techniques
might influence reported results in some way or another.
Among other aims, this paper will test whether some of the explanations proposed
by scholars as being responsible for the vast heterogeneity in income elasticities of health
expenditure results are indeed valid. By employing meta-regression analysis, the present
study will examine and test systematically whether the differences in study character-
istics and employed methodologies truly contribute to inconsistencies in empirical out-
comes, and will generate an estimate of how much and in what precise direction these
characteristics change reported elasticities. In an area flooded with studies pointing at
different results, as is the literature on the determinants of health care expenditure, a
meta-analysis seems to be the perfect tool to make some light.
Chapter 2
The long road to meta-regression
analysis
”Meta-analysis refers to the analysis of analyses...the statistical analysis of
a large collection of analysis results from individual studies for the purpose
of integrating the findings”(Glass 1976 in Rudner et al. 2002).
Once in a while, is useful and necessary to look back at the studies accumulated in a
research field and summarize the knowledge of what has been found empirically, instead
of adding a new study to the pile. By doing so, both consistencies and irregularities of
previous findings can be emphasized, in order for the next study to be designed starting
from what has generally been agreed upon until that moment. As Glass (1976, p.4)
states in his seminal paper for meta-analysis research, there is a need for finding ”the
knowledge that lies untapped in completed research studies” and to use the appropriate
methods ”so that knowledge can be extracted from the myriad individual researches”.
When trying to understand the concept of meta-regression analysis it is essential to
firstly emphasize the difference and improvements this method brought to its predeces-
sors, the meta-analysis and the narrative review. For illustrative purposes, Figure 2.1
briefly summarizes the evolution and essential differences between the methods.
2.1 Narrative review
A narrative review offers a summary of the literature on a specific field of research and
compiles the results reached until a certain moment in time. Mainly, narrative reviews
are descriptive and do not involve a systematic search of literature. Instead, studies are
selected based on availability or the author’s personal selection (Uman L.S. 2011). Typ-
ically, some papers are discarded from the analysis due to methodological inadequacies,
unreliability of the data or other criteria considered important by the author, which has
led many scholars to state that narrative reviews are, in most cases, characterized by
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Figure 2.1: Methods of summarizing literature findings
Source:author’s own compilation.
selection bias, whilst the legitimacy of choice of papers is highly questionable (Weich-
selbaumer 2005, p.480). A narrative review of the same literature can reach opposite
conclusions, precisely due to the subjectivity and its reliance on the author’s convictions
or interests.
Apart from not providing comprehensive information on the methods used to select
papers included in the study, narrative reviews are rather vague when it comes to
disclosing information on characteristics of the data, ways in which it was collected,
period of time covered by the literature or characteristics of the individual studies
(Beaman 1991). What is more, a common way of reviewing the literature is by counting
the number of studies supporting various results and endorsing the idea that received
the most votes – the so called ”vote-counting” technique. The procedure is clearly
biased, since it does not take into account the research design, sample size or any other
characteristics of the study’s design. Last but not least, one reviewer can only deal
with a small number of studies. The more information becomes available, the harder
it is to evaluate it using this technique. It can thus be summarized that, while being
informative and acknowledging the problems existing in the empirical economic research,
conventional narrative reviews do not resolve them (Stanley 1998).
Among the encountered narrative reviews in the literature, only one focuses on
analyzing the studies on drivers of health care expenditure, and that is Mart́ın Mart́ın et
al. (2010) ’Review of the literature on the determinants of healthcare expenditure’. This
study reviews solely papers published between 1998 and 2007, concerning exclusively
OECD countries. Van Elk et al. (2010) also offers a short overview of the literature
regarding the factors which influence health care expenditure, estimating in addition
their own model. These two papers are particularly important for the present research,
since they represent the starting point for constructing the database of studies to be
analyzed by our MRA. More details regarding the dataset will be offered in chapter 4.
2.2 Meta-analysis
Meta-analysis, on the other hand, is “a more rigorous alternative to the casual, narrative
discussions of research” (Phillips & Goss 1995, p. 322). While, as the narrative review,
it analyzes and synthesizes the results of the literature on a certain topic, it does so
using statistical tools. Meta-analysis does not replace the narrative review technique,
but it rather accompanies and grounds the results reached by it. It is more objective
and quantifies the results reached in the literature, providing a measured averaged of
each study’s outcome.
Although the statistical basis of meta-analysis was built well before his time 1, the
statistician Gene V. Glass is recognized as the one who coined the term“meta-analysis”.
He defined it as “the statistical analysis of a large collection of analysis results from indi-
vidual studies for the purpose of integrating the findings” (Glass 1976). In this seminal
work, he calls for attention being drawn on the importance of extracting knowledge
from gathered studies and although his investigation was focused on the analysis of the
educational area, meta-analysis soon became adopted in many fields of research. Due to
the improvements it brought to traditional narrative reviews, starting from mid 1980’s
the number of papers using meta-analysis grew exponentially (Figure 2.2).
The central element in meta-analysis is the “effect size”, which could show the result
of an intervention, the power of a relation between two variables or the estimate of a
distinct value (Borenstein 2011, p.4). As defined by Glass, the effect size represents the
mean difference on the outcome variable between treatment and control groups divided
by the control group’s standard deviation:
g = (µe − µc)/σ (2.1)
where µe is the mean of the experimental group, µc represents the mean of the
treatment group and σ is the standard deviation of the control group (Glass 1976, p.6).
The effect size represents the common denominator of the literature being analyzed
and is used to compare estimates from different studies. Research might report estimates
measured in different metrics, i.e elasticities, semi-elasticities, correlations, regression
coefficients, but they can all be transformed into the common metric which is the effect
size and later be compared. This idea is fundamental in understanding how meta-
analysis, and further meta-regression analysis works, since the effect size represents the
dependent variable of the meta-regression model.
1 The first methods of quantitatively summarizing the results reached by all studies in a certain
field of research was first introduced by George Biddell Airy in his 1861 book ’On the algebraical and
numerical theory of errors of observations and the combination of observations’
Figure 2.2: Number of publications employing meta-analysis, 1986-1999
Source:Egger et al., 2008, p.23
Basically, each study in the literature considered for evaluation is characterized by
an effect size. After weighting each study according to its effect size’s precision, namely
the inverse of its standard error, an average effect can be computed, which is a more
precise and robust estimate of the ”true effect” than the individual estimates provided
by each primary study. This is, in fact, the major aim of meta-analysis: providing an
estimate with an increased statistical power that could reveal statistical significance in
a research field where conclusions are mixed and vague.
For a long time, meta-analysis was used in the field of medical research and psy-
chology, where performing new trials was a rather expensive process, both in money
and lives (Stanley 2001). Borenstein (2009) emphasizes how pharmaceutical companies
summarize the data from studies on the efficacy of a drug, providing a more powerful
and precise estimate of its effect. Meta-analysis proves helpful also when evaluating the
side effects of a drug, especially since cases are more rare, and thus primary studies are
more scarce (Borenstein et al. 2009).
Meta-analysis can solve a number of shortfalls present in narrative reviews:
• the lack of transparency and high subjectivity problem. A meta-analysis will
offer all the details regarding the techniques used to search the literature and
criteria on which studies are included or excluded from the analysis, the methods
used for performing statistical analysis and the mechanism for disseminating the
results (Borrenstein 2009, preface). Also, the author’s own views do not have
such an influence on the results as they do in narrative reviews, since the weight,
corresponding to the importance, assigned to each study is based on mathematical
criteria;
• the replication problem. Since meta-analysis offers detailed instructions on the
methodology employed, research can be replicated by scholars interested in study-
ing the same topic and observing that results produce various changes in the data
set, variables chosen or methods used;
• the aggregation problem. The more studies included in a review of the literature,
the harder it becomes to analyze them through descriptive methods. The human
mind could generate an overall conclusion and summarize subjectively the results
of 30 studies, but when faced with the analysis of 200 studies or more, it is faced
with an impossible situation (Rudneret al. 2002). Meta-analysis makes things
possible, employing statistical methods and statistical software, coding the results
of each study and using a common metric for all outcomes, in order to make them
more comparable;
• the ambiguity problem. Very often, narrative reviews provide vague results, that
are difficult to use by policy makers. By providing a measure of the average
outcomes, the results of a meta-analysis are more usable.
However, meta-analysis has its limitations. One often-mentioned criticism refers
to the inadequacy of drawing conclusions by comparing and pooling studies that use
different measurement techniques and variables. Also, meta-analysis often considers
multiple outcomes that come from the same study, which might over-represent some
papers and under-represent others. Another problem pointed out is that meta-analysis
includes both unbiased, robust studies and papers whose design is questionable. This
aspect of methodology is suspected of providing an overall estimate that might be biased
and not representative. Finally, the issue of publication bias arises, referring to the fact
that meta-analysis results might be biased also due to the fact that published research
might favors studies reporting a certain result, while those papers which do not follow
the pattern seldom get published (Phillips and Goss 1995).
The concepts of treatment and control group, as were introduced by Glass in defining
the effect size (Equation 2.1), might seem unsuitable for economic research, as in the
present case. Fortunately, meta-analysis started being used on a large scale in social
sciences as well, of special importance being Stanley and Jarrell’s initiative (1989) of
employing meta-analysis in the field of economics. Trying to address and offer solutions
to some of the limitations of meta-analysis listed before, they developed the specific
procedure of assessing empirical economic research: meta-regression analysis.
2.3 Meta-regression analysis
The first article on the use of meta-regression analysis in the field of economics was
published in 1989 in the Journal of Economic Surveys. Unlike meta-analysis, which
only offers a weighted average of the studies’ effect size, MRA goes further and tries
to clarify and quantify the causes of heterogeneity in estimated effect sizes between the
primary studies. MRA works as a typical regression analysis, in which the population
is no longer composed of individuals or countries, but of primary studies. Different
estimates of a given coefficient inside a primary study may be treated as individual
observations(Rose & Stanley 2005).
In the last decade, MRA was employed to look at a variety of topics: the effect of
state and taxes on economic development (Phillips & Goss 1995), the factors that explain
local privatization (Bel & Fageda 2007), the effect of common currency on international
trade (Rose & Stanely 2005), gender wage differences (Weichselbaumer & Winter-Ebmer
2005), the effect of immigration on labour markets in the host country( Longhi, et al.
2005), the link between economic freedom and economic growth (Doucouliagos 2005) or
the determinants of horizontal and vertical spillovers from FDI (Havránek 2013).
By definition, MRA includes all studies, published and unpublished, on a speci-
fied topic (Stanley & Jarrell 1989). The differences among primary studies, e.g. the
methodology employed, the ways in which variables are measured, robustness of esti-
mates or tests applied, should not represent a reason to eliminate studies from the data
set, but instead offer more grounds to include them and control for their effect on the
meta-dependent variable – the effect size. If papers are excluded from the analysis, the
reasons of the choice have to be explained in detail (Stanley 2001). This procedure
greatly minimizes the subjectivity of the selection process and promotes replication by
others interested in the meta-analyzed area of research or by the method itself.
In an MRA, a central point of interest is held by the meta-explanatory variables.
In the end, a researcher undergoing a meta-regression research is interested in knowing
how different model specifications or characteristics of the primary studies influence
their estimates. Some possible characteristics of a study that could be employed as
meta-regressors are: a researcher’s age, gender, nationality or level of income, data
used, variable definition, year of publication of study, source of funding of research,
methodological characteristics of the paper etc. (Stanley et al 2006, p. 284).
Apart from being able to explain heterogeneity in reported results from a specific
field of research, MRA addresses another important problem: publication bias2. When
aggregating the results of various papers, the main bias the researcher is faced with is
the fact that literature might be missing those studies that do not provide the results
editors or researchers favor. Type I bias refers to the case when papers reach results
bearing a different sign than the one preferred by editors or authors, e.g. if a study
2Staneley & Doucouliagos (2012) also refer to the term ’selective reporting bias’, since authors
themselves choose not to report insignificant or not preferred results
would reach the conclusion that per income capita has a negative influence on per
capita health expenditure, there might be a tendency to discard these results, since the
consensus among researchers is that an increase in income levels triggers an increase in
per capita total health care expenditure. Type II bias appears when papers reporting
insignificant results do not get published, since editors find they are not a ’good story’
for publication (Havránek 2013, p.15).
Publication bias gives overall reported estimates a distorted value, which can have
considerable consequences for policy makers. If a literature is affected by publication
bias, then the MRA sample will be biased and the probability of committing a statistical
type II error, i.e accepting a false null hypothesis, is higher. MRA can correct for
publication bias and provide an estimate of the true effect beyond the contamination of
publication bias. More about the ways in which this can be achieved will be presented
in the next chapter.
To sum up the main points, it could be stated that narrative reviews are a good
tool for getting a general overview of the results reached in a certain field of research,
but the examination is excessively subjective and once the number of evaluated papers
grows, it becomes difficult to offer reliable outcomes . Meta-analysis manages to quan-
tify the results reached in the literature and offers an average effect size, but it is highly
biased, since it does not account for the results of those papers which might not have
been published. While it offers a quantitative measure of the outcomes from a research
area, it does not try to account for the primary study characteristics that might in-
fluence reported estimates. Meta-regression analysis seems to be the best alternative
when trying to summarize and interpret the findings of economic research. Its main
shortcoming, the exposure to publication bias, is also encountered in narrative reviews
or simple meta-analysis, but unlike these approaches, MRA uses objective, replicable
methods, identifies and removes publication bias and explains the heterogeneity in re-
search findings (Stanley & Doucouliagos 2008).
Chapter 3
Methodology
As previously mentioned, the central idea in MRA is the effect size. This represents
the estimate of the relation of interest, which in our case is the influence income has
on aggregate health expenditure levels. Primary studies might report estimates using
different measures, e.g. elasticities, semi-elasticities, partial correlations. These should
be transformed into a common metric to allow further comparisons and assessments of
overall results. Once the conversion completed, that metric will represent the effect size
and will be introduced in the MRA model as the dependent variable.
The literature assessing the drivers of health care expenditure generally uses a vari-
ation of the following regression model:






Pi + uit (3.1)
where PHEit is per capita health expenditure, PCIit is per capita gross domestic
product, Demandit represent the demand side variables (e.g. percentage of population
over 65 years, mortality rates, life expectancy, urbanization), Supplyit represent the
supply side variables (e.g. number of physicians per 1000 people, no. of acute care beds
per 1000 people, relative price of health care), Yt are year fixed effects, Pi are country
fixed effects, uit is the error term and i and t index the cross-section and time period,
respectively.
The reader will be asked to interpret this model only as the frame upon which
are constructed the regression equations encountered in the literature. Depending on
the type of data used and independent variables considered by researchers, there exist
variations. For example, many studies focus solely on the influence of income on health
spending and as a result the only independent variable included on the right-hand side
is PCI (eventually, alongside time and country effects for panel data). The choice in
additional supply and demand-side variables also differs, in accordance to what the
researcher might consider to be a possible influence on health spending. Finally, papers
employing cross-sections can not include any country or time-fixed effects.
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3.1 Choice of effect size
What we are interested in from Equation 3.1 is the estimate of β1, which shows the
effect per capita income exerts on aggregate health care spending. It has become rather
a consensus in the literature of the drivers of health spending that the log-log functional
form is preferred to others, which means the coefficients are the direct estimates of
elasticities. Since elasticities are non-dimensional, it is possible to compare them within
and between different studies, and thus prove to be an adequate effect size for our
MRA. The elasticity exhibits the two important proprieties of effect size, namely it
measures the effect of one variable on another, and is comparable between and within
studies, since is a dimensionless value (Stanley & Jarrell, 1989). Thus, the estimated
health spending income elasticity reported by each primary study was collected and
introduced in our MRA analysis as the dependent variable.
Where studies use the log-log functional form, estimated coefficients of the income
variable could directly be interpreted as elasticities. However, a number of papers
employ models in levels. In some cases, alongside the estimate of coefficients, they also
offered information on elasticities values (e.g. Parkin et al. 1987). In case elasticities
were not reported, it would be possible to calculate their value at the mean1. However,
the studies we encountered did not normally report any information on sample means
of independent and dependent variables, which meant that we could not include these
papers in our dataset, as the effect sizes would not be comparable.
The next issue appears when referring to standard errors. In MRA, the standard
errors are needed in order to appropriately weigh each primary study when computing
the averaged effect size or when estimating the multiple MRA. If a primary study uses
the double-log function and reports the standard errors of its coefficients, these can
further be employed directly as the standard error of our effect size. In some cases,
papers did not report standard errors, but offered t-values instead. Standard errors
were then computed using the formula:
t = η1/SEη1 (3.3)
where η1 represents the estimated income elasticity, t is its t-value and SEη1 stands
for its standard error.
Other studies only report the p-values of the estimates. When degrees of freedom are
mentioned or can be computed from the information provided by the paper, we derived
the t-statistics using the TINV function in Excel, and then computed the standard error.
We also happened to encounter studies that only exhibit the level of significance, using
1The elasticity can be calculated using the formula
η1 = α1X/Y (3.2)
where X represents the sample mean of the explanatory variable and Y stands for the sample mean of
the dependent variable.
***,**, and * for significance at 1 percent, 5 percent and 10 percent levels. In this case,
we followed the example of Greenberg et al. (2003), and assumed the p-value is located
at the midpoint of statistical significance scale. For example, an estimate significant
at 1 percent level was assumed to have a p-value of 0.005; an estimate significant at 5
percent level was given a p-value of 0.03, while an estimate significant at 10 percent level
was assumed to have a p-value of 0.075. This method does introduce some measurement
error in the dataset, but it was considered to be a better option that eliminating these
studies altogether.
Moreover, those studies not measured in log-log functional form, yet still reporting
elasticity values, did not usually declare the standard error of the elasticity, but only
the regression coefficient’s one. Regarding this aspect, Stanley & Doucoulagios (2012
p.27, further referred to as S & D 2012) recommend that in case the standard error of
elasticity cannot be computed 2, due to unreported needed information, it is possible
to use the standard error of the coefficient instead. They claim that the precision error
introduced by using this method would not be as a big concern as the publication or
misspecification biases the literature might suffer from. When checking for publication
bias and heterogeneity in reported income elasticities, we considered the t-values of the
regressions coefficients, from where it was further easy to compute the standard error
of the elasticity, using eq. 3.3.
When a paper reports both long-run and short-run income elasticities of aggregate
health care costs, we collect only the long-run estimates, again following S & D’s (2012)
recommendations. We also find it to be a more appropriate estimate, since the short-run
elasticities measure the dynamic relation between income and health care expenditure
and the rate at which the relation between the two would reach its equilibrium state
after an alteration in one of the variables. The long-run elasticities, on the other side,
estimate a more stable relation between the two variables and can suit our analysis
better.
Finally, the issue of multiple estimates reported in a primary study should be ad-
dressed. Numerous studies included in our dataset report multiple estimates, either
resulted from the estimation of nested models, usage of different techniques or employ-
ment of different data. S & D (2012) present various possibilities of tackling this issue.
The first one would be to report one estimates per study, coming from the model ex-
plicitly preferred by authors themselves or resulting from the most robust and with
the highest explanatory power model. This approach will generate a scarcer data set,
and might also introduce selection bias, since the meta-analyst must select an estimate
based on certain judgments.
The second possibility would be to collect all effect sizes reported in a study and
compute the weighted average of them, alongside the weighted average of the standard










2 varY , where varη1 = the variance
of elasticitiy, and X, Y are the sample means of the independent and dependent variable, respectively.
errors. The magnitude of the effect sizes, in this case, will be different than when using
the first approach, which will clearly provide different results, closer to the overall value
of all estimates reported in the literature. Nonetheless, this approach does not increase
the number of observations of the MRA and also disregards the differences in methods
used to estimate the reported effect sizes.
The third method, which was the one employed in the present study as well, consists
of considering all estimates reported by each study, coding for the differences in methods
and estimation techniques which were used to obtain them. One advantage is that
it greatly increases the size of the database, offering thus more degrees of freedom
and space for testing the effect of more meta-independent variables on the effect size.
Secondly, since differences between methods used for computing each effect size will be
controlled for, it also has a greater potential to explain the variability in estimates of
health spending income elasticities and identify those meta-regressors responsible for
the heterogeneity among reported estimates of the elasticity.
When MRA started being used, it was believed that the best option was to pick one
observation per study(Stanley & Jarrell 1998). Nowadays, conventional practice agrees
that the use of all estimates, which are weighted inside a study, while also modeling
for within-study dependence by using multi-level MRA, is the best practice. Including
more than one estimate from a single study brings about the possibility of dependence
in the data, but MRA has a solution for this problem.
In meta-regression analysis, the studies included are assumed to be a random sample
of the distribution of effect sizes. The mean of this distribution is represented by the
combined effect estimates (Borrenstein et al. 2007, p.4). Some critics of meta-regression
analysis claim that combining and averaging the results of studies which differ in quality
might provide biased estimates. This issue could easily be fixed by introducing in the
MRA a measure of quality of the estimates collected from the literature. For our
research we use the precision, i.e. the inverse of and estimate’s standard error, as such
a measure. This way, studies which report estimates of lower quality, i.e with a higher
standard error, will be given less weight when computing the overall effect estimated in
the literature.
The weighted average effect size, which in this case is the average of all health







where wi are the weights used and ηi are the estimated elasticities in each primary
study. When it comes to weights, it was suggested that the optimal case would be to use
the inverse of the estimates’ variances (Stanley & Doucouliagos 2012, p.46; Borrenstein
et al. 2007, p.7). As a sensitivity analysis, the average effect size was also computed
using as weight the inverse of the number of effect sizes a study reports. For example, if
a paper provided 10 estimates of income elasticity on health expenditure, each estimate
was weighted by a measure of 1/10. Next, the standard error of the average effect was
computed as the square root of the reciprocal of the sum of the optimal weights (S &






3.1.1 The average effect size
The computation of the average effect size was done in two ways: using fixed effects
average estimators (FEE) and random effects average estimators (REE). It must be
noted that in MRA fixed effects and random effects estimators are not the same as
the ones encountered in panel data regression analysis. We will use the FEE and REE
acronyms when referring strictly to the averaged effect estimator method.
FEE assume that all effect sizes come from the same ”true effect size” and have been
extracted from the same population. When computing the average weight, each effect
size is weighted by its squared precision. Thus, an estimated fixed effect will equal the
true effect size plus a within study error (Ti = Θi + εi). In contrast, REE weigh each




i estimates the within-study variance
and S2h estimates the between-study variance. Random effect estimators assume that
the true effect size varies from study to study. When using REE, one estimates the
mean of a distribution of true effects, since there is no unique true effect for all studies.
That is why the weights under the REE have to account for both within and between-
study variances (Ti = Θi + ζi + εi)(Borrenstein et al. 2007, p.5). The average effect size
computed with the REE still uses Equation 3.5, but this time the total variance will












The choice between FEE and REE should be made according to the studies included
in the database. If one believes the studies have the same underlying true effect, FEE
could be used. In comparison, if data is collected from studies performed by others,
chances are the data is not identical and the true effect size differs from study to study.
In this case, REE would be more appropriate. Since our database is composed of studies
which use data from different regions and different methodologies, we have reason to
suspect the underlying effect size differs, which is why REE will be a more appropriate
way of averaging the income elasticities of health spending reported by the literature.
3.1.2 Publication bias
One of the important contributions of MRA to normal meta-analysis is the sorting of
publication bias and modeling of heterogeneity. Publication selection appears when
studies are left out of the public reach, because they are not published. Two reasons
can lie underneath this bias: either the results have a direction which is not preferred
by referees, editors or authors, either the outcomes of the study are not significant and
therefore do not represent a ”good story” for publication (Havránek 2013, p.15).
As a first step in uncovering publication bias, we graphically represented our data
using a funnel plot. Income elasticities were plotted against their precision, i.e. inverse
of standard error. Theory states that if the scatter plot resembles an inverted funnel
shape, with more precise estimates closer to the average value, and it displays a sym-
metrical distribution of effect sizes, then most probably the literature does not suffer
from publication bias 3. Otherwise, there is a high risk the literature is contaminated
by publication selection (S &D 2012).
Apart from the funnel graph, which only offers a glance at publication bias, MRA
can test for its presence in a more formal way, employing a simple regression which
reformulates the funnel plot. This bivariate regression emphasizes the relation between
the estimate of income elasticity and its standard error. In the absence of publication
bias, reported effect sizes will be independent of their standard errors, as is assured
by random sampling theory. In the case of publication selection, the estimated effect
size of each primary study will be correlated with its standard error, ceteris paribus (S
& D 2012). The explanation for this correlations, as given by Stanley (2012), is that
researchers who have small samples and thus large standard errors will have to look
more for larger estimates and test with various model specifications and statistical tech-
niques in order for their outcomes to have a statistical significance. On the other hand,
researchers with more numerous samples and smaller standard errors have practically
infinite model specifications to find statistical significance and do not need to search so
hard (Stanely 2008). Also, since journals are more likely to publish significant results,
the standard error of an estimate is normally considered a good indicator of precision
or publication bias. The idea can be translated into:
effecti = β0 + β1SEi + εi (3.7)
where effecti is the effect size, i.e. the income elasticity estimate reported by study i,
SEi is its standard error and εi is the error term. The term β1SEi models for publication
bias, while estimates of the intercept β0 provide corrections for publication selection (S&
D, 2012, p.61). The corrected estimate will basically represent the difference between
the unweighted average effect and the estimate for publication bias (β1SEi). Previous
scholars have found that in fact, when correcting for publication bias, a better measure
is provided when using the variance instead of the standard error of the effect sizes and
we will estimate our model by using also this variation.
Since in equation Equation 3.7 the dependent variables is the effect size and the
3Publication bias will still have to be tested by means of regression analysis.
independent variable is a sample of estimates of its standard error, the error term
εi will not be similarly and independently distributed. In consequence, the model is
heteroskedastic. In order to eliminate this problem, we estimated its WLS version, in
which all components are weighted by the inverse of the squared standard error of the
corresponding elasticity.
Attention was paid to the issue of dependence among estimates of elasticities, to
which we briefly referred when computing the FEE and REE average effect sizes. Most
of the studies included in our database report more than one estimate of income elasticity
of health expenditure, which raises questions regarding the dependence between these
studies, which might make Equation 3.7 misspecified. As a robustness check, the simple
WLS MRA was also estimated by ways of a mixed-effects multilevel model, which
controls for unobserved between-papers heterogeneity (S& D 2012 p. 69). This model
is an equivalent of the random-effects model used in panel data regressions. The formula
we employed for our estimation is:
effecti = β0 + β1SEis + µs + εis (3.8)
where i stands for the estimate number,s is the study number, µs is the unobserved
study effect and εis represents the between-studies unobserved effects.
The mixed-effects multilevel model is appropriate for MRA, as it considers unbal-
anced data and thus employs the restricted maximum likelihood estimator (MLE) in-
stead of generalized least squares (GLS) (Nelson & Kennedy 2009 in Havranek & Irsova
2010, p. 10). A test on the null hypothesis: H0 : β1 = 0 will reveal whether the lit-
erature on drivers of aggregate health expenditure suffers from publication bias (if the
null hypothesis is rejected). This test is called the funnel-asymmetry test (FAT) and its
results are presented in section 5.1.
Once the FAT test revealed the presence of publication bias, although a low one,
we continued our analysis by checking whether there exists a genuine empirical effect,
beyond the small distortions in estimated effect sizes brought by publication bias. This
was achieved using the precision-effect test (PET), which tests the null hypothesis :
H0 : β0 = 0 of the same simple MRA equation (3.7). Rejecting the null hypothesis
ensures there is a true empirical effect of income on health care expenditure. It should
be noted that the FAT and PET test have their shortcomings; more precisely, FAT is
known to have a low power (Stanley 2008), while the PET can point at the existence of
a genuine effect size, even when there is none (type I error).
Finally, after proving the existence of a true effect size, beyond any influence of
publication bias, we estimated its value using the precision-effect estimate with standard
error (PEESE) test. It was mentioned before that various simulations performed by
scholars found that using as independent variable in (3.7) the variation of the estimated
effect size, and not simply its standard error, provides more reliable results for the
coefficient on precision if publication bias is proved to be even slightly present(Stanley
& Doucouliagos, 2011). The equation used for estimating the model is:
effecti = β0 + β1SE
2
i + εi (3.9)
The PEESE estimate should be used in those cases where there is a suspicion that
a true underlying effect size exists. This means that if the PET test rejects the null
hypothesis, then one can estimate the PEESE and it will provide better estimates of
the genuine effect than PET would. In our case, since the PET test provided results
which indicated the existence of a true effect size, we were able to estimate its value
more reliably by using the PEESE test.
3.1.3 Multiple MRA
Once publication bias has been identified and a measure of the true effect has been
estimated, a further step in analysis was to uncover what causes the excess heterogeneity
in reported estimates of income elasticities of health care expenditure. For this purpose,
different characteristics of the primary studies believed to affect the reported outcomes
were collected and coded and then employed in a multivariate MRA.
The multivariate MRA model is similar to the simple MRA one , with the difference
that it includes the extra-explanatory variables:
effecti = β0 + β1SEi +
∑
βkZki + εi (3.10)
where effecti represents the estimated income elasticity of health spending, β0 is the
intercept and estimates the true income elasticity value, SEi is the standard error of
reported income elasticity, β1 is the coefficient that measures the existence of publication
bias, Zki represent the meta-independent variables that explain the heterogeneity in
reported outcomes of the literature, βk are the coefficients that measure the effect of
these variables on reported income elasticites of health care expenditure and εi is the
error term.
Most of the previously cited papers which employ MRA use a general to specific (G-
to-S) modeling technique, in what appears to be a general methodological consensus.
This approach implies estimating a model where all variables are included, followed by
the exclusion of all insignificant variables one-by-one, while checking at every step the
validity of the transformations (Campos et al. 2005). While some scholars state that
the G-to-S approach is a good tool for producing a structured model and avoiding data
mining (S&D 2012, p 91), others believe that a G-to-S strategy is statistically dubious
and the outcomes of such a modeling technique greatly depend on the order in which
the variables have been excluded and the data has been altered (Pagan 1987).
Our multiple MRA analysis was carried out in two directions. The first one started
with the estimation of a model which included all the meta-independent variables pre-
sented in table 4.3, as in the G-to-S approach. Those insignificant moderator variables
were then eliminated one at a time until only those with a p-value ≤ 0.05 remained.
Correlations between variables were also taken into account when performing the elimi-
nations. However, this does not represent our main approach, and results of the G-to-S
modeling can be consulted in the Appendix D, as means of comparison with the mod-
eling technique we preferred, which is a bottom-up approach. Starting from the simple
MRA model, meta-independent variables were gradually added, checking at every phase
for the significance of the newly added regressors and their effect on the joint significance
of the MRA model.
Chapter 4
The data
4.1 Construction of the dataset
The final dataset is comprised of 220 elasticities gathered from 54 studies; a list of
studies included in the MRA alongside the number of estimates collected from each
one can be found in Appendix A. On average, a study reports 4.1 estimates, with a
maximum of 20 reported estimates per study and a minimum of 1 estimate per study.
The oldest research paper dates from 1977 and the most recent was published in 2013.
The dataset contains studies which exhibit many differences in the methodology and
data they employ. We tried to include as many of these studies as long as their outcomes
could be compared or transformed into a common metric, and we coded and controlled
for the observed differences in data or methods in the multiple MRA.
The database construction started from two narrative reviews of the literature on
drivers of health spending: Mart́ın et al (2011) and Van Elk et al. (2010), which were
referred to previously. Regardless of the differences in scope of these two papers and the
present one, the two studies proved to be very helpful for the current research, especially
their references and citations, which pointed various studies that could be included in
our MRA. A total of 42 studies were collected from the references of these two reviews.
In addition, a search in PubMed, Scopus, JSTOR, Google Scholar and EBSCOhost
online databases using the keywords: ”health expenditure”, ”spending”, ”costs” ”de-
terminants”, ”income”, ”ageing”, in a variety of combinations, added 99 more studies
to the data-set. Lastly, 7 additional empirical papers were discovered while reading
through the references of various studies on the topic of health expenditure, so we
included them as well. The results of the search are presented in Table 4.1.
As can be seen above, the initial search yielded a number of 148 total studies.
Nevertheless, as previous scholars often mention as one of the shortcomings of meta-
analysis, there is no guarantee that all studies on a certain topic are gathered after
the search (Rose & Stanley 2005). In this particular case, the keyword search in the
online databases might have failed to spot important articles which offer estimates of
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Table 4.1: Data sources
Database Number of studies
Martin Martin et al. paper (2011) & van









the effect of income on health expenditure, but do so as an auxiliary theme. Other
important articles that defined their topic using a different terminology might have
been overlooked as well. Thus, there is no guarantee that our initial sample of studies
managed to gather all econometric investigations on the effect of income on health
expenditure and therefore results should be interpreted with caution.
On the other hand, various papers identified by the search proved irrelevant for the
purpose of the present study, i.e. did not employ econometric analysis, analyzed only
one segment of health expenditure, such as public health expenditure or out-of-pocket
payments, did not offer elasticity estimates or enough information for calculating them,
did not employ income among their explanatory variables, etc. Thus, further selection
criteria were implemented, in order to reduce the sample of studies to those offering
comparable effect sizes, i.e elasticities. Papers which were included in the final sample
of studies had to pass the following selection criteria:
(a) Use econometric methods and more specifically, regression analysis;
(b) Include income among their explanatory variables;
(c) Look at the determinants of health expenditure at a macro-level, i.e consider
health care expenditure at a country/ state/ regional level, and not individual or house-
hold expenditure on health. This criteria was implemented for comparability reasons,
since health expenditure decisions at individual and aggregate level are fueled by differ-
ent reasons.
(d) Define as dependent variable aggregate health expenditure, and not merely a
segment of it, such is public health expenditure or out-of-pocket payments. A compari-
son between these different types of health costs would render ambiguous results, since
these entities are not comparable and different drivers might be behind their evolution.
(e) Use the double-log functional form and report clear estimates (p-values, t-values,
standard errors), or otherwise, provide the appropriate statistical information needed
for computing the effect size and its standard error;
(f) Are published in English .
Table 4.2: Average effect size
Average effect size Value
Unweighted 1.0455
FEE (s.e) 1.122 (0.002)
REE (s.e) 0.921 (0.021)
95% CI (unweighted) 0.943 to 1.1578
95 % CI (FEE) 1.117 to 1.127
95 % CI (REE) 0.879 to 0.963
After applying these selection criteria, the studies which complied with all require-
ments and were included in our final database were in number of 54 and provided 220
elasticities. As a point of reference, Doucouliagos & Stanley (2012) found after review-
ing 87 meta-analysis that, on average, a meta-analysis included 35 studies. Appendix
B provides the list of all the papers not considered in our final database, alongside the
reason for their exclusion.
4.2 Meta-dependent variable: the income elasticity of ag-
gregate health care spending
The collected income elasticities of health expenditure, as reported in the literature,
vary from a minimum of -0.429 to a maximum of 6.33, with a standard deviation of
0.707. Half of the reported income elasticities lie below the value of 0.940, while the
top 10 % of results are above the value of 1.68. The unweighted mean is 1.04, placing
the average income elasticity close to unity. We also computed the unweighted average
effect for only those elasticities corresponding to t-values situated above the 75th per-
centile, since higher t-values are associated with greater confidence in the estimate, and
thus the resulted averaged effect size should also exhibit greater reliability. In this case,
the mean value resulted to be approximately the same, at 1.050 value, with a 95 % con-
fidence interval of (0.94, 1.15). However, as previously explained, the unweighted mean
is in most cases a misleading statistic, since effect sizes have different precisions, mean-
ing their weight in the final average effect size should vary according to this precision.
Therefore, we also computed the weighted average, which provides a more robust esti-
mate. Table 4.2 presents the values of the unweighted average, FEE and REE average
effect size, therefore the average income elasticity.
It can be noticed that the weighted FEE and REE averages are different than the
unweighted value. Under the FEE assumption, health care expenditure appears to
be income elastic, with an elasticity of 1.122 and a low standard error of 0.002. REE
average elasticity, on the other side, is slightly below unity at 0.921, which would situate
health care in the necessity good category. It should be noted that it also has a higher
standard error (0.021)than the FEE one, which makes it less precise.
If we would have the certainty that the elasticity estimates from which these average
values have been calculated represent a random sample of all health expenditure income
elasticity estimates existing in the literature, then the weighted effect would be unbiased
and would represent a trustworthy measurement of the average effect size. Nonetheless,
the presence of publication bias would translate into a sample of population effects
which is not random, meaning that the weighted effects we have computed might be
distorted, even for the REE estimate, which accounts for between-study variance. Since
in fact we suspect slight publication bias in the literature, the averaged effect size cannot
be considered a trustworthy representation of the outcomes reached in the literature.
Instead, a more accurate representation will be the ”true” effect size, which will be
presented in chapter 5 among other results of the MRA analysis.
Graphic tools offer a general picture of the data and uncover possible problems, such
as outliers. The frequency distribution of our effect sizes follows in certain measure a
normal distribution. Considering that the estimated elasticities were extracted from
regressions using the double-log function, this is somewhat expected. Most of the values
lie around unity, while some elasticities exhibit values that are not in line with the
majority of estimates.
Figure 4.1: Frequency distribution of income elasticities
Another visual representation of the dependent variable observations distribution
was obtained by plotting the income elasticity against its precision, in a funnel plot. As
it can be seen from Figure 4.2, there is a general trend of values being clustered around
Figure 4.2: Funnel graph of income elasticity of health care spending
the FEE averaged income elasticity value, which is represented by the thick line and
corresponds to the value of 1.122. The thin line represents the REE averaged efect size.
Nevertheless, a number of elasticities estimates appear to be outliers and leverage
points. These values were inspected, in order to discover whether they are coding errors,
or actual outliers. The outliers, which signify the amounts with a low precision but very
large value of the elasticity estimates, were retained in the database, since at the moment
when they will be analyzed in the MRA, they will exert a low influence on the results.
The reason for this is because they are weighted by measure of their precision, and since
their precision is low so will be their influence.
The leverage points, on the other side, exhibit a very high precision and therefore
can have a large influence on the results of the MRA. Our data seems to exhibit some
values that could be considered outliers and levarage points. The papers from which
these values were extracted were double checked, in search of possible coding errors.
However, none were discovered, thus the values were kept, expecting for the reasons of
this heterogenity to be revealed by the multiple MRA analysis.
It is obvious the funnel does not have a symmetrical shape, since values at the right
of the graph seem to be missing and are more scattered than those on the left-hand
side, pointing at the possibility of insignificant estimates (elasticities with low values
and large standard errors) having not been reported. This visual inspection indicates
the literature is affected by publication bias. Opinions on the income elasticity of
aggregate health care expenditure appear to be mixed, with roughly half of estimates
(49%) reporting a value below unity, and the other half (51 %) uncovering elasticities
higher than one. When looking only at the top 10 % most precise estimates, which
due to their high precision are less likely to be affected by publication bias, 68 % have
elasticities higher than 1, while the rest of 32 % elasticities are below unity.
4.3 Meta-independent variables
We assumed that a number of study characteristics could explain the heterogeneity in
health care spending income elasticities reported by the literature:
- degree of aggregation of data. A number of scholars have suggested the income
elasticity of health care expenditure behaves differently, depending on the level at which
is analyzed. Getzen (2000) found that health care is a necessity at the individual level
and behaves more like a luxury good at the national level. Furthermore, there have been
some voices in the academic environment stating that performing comparisons of health
care expenditure at the international level could be problematic, due to the institutional
differences in health care systems, different levels of development between countries and
different types of governance. Our MRA includes a dummy variable accounting for the
level at which the primary study performs the analysis, whether between-countries or
regions inside a country. We expect studies developed at a lower level of aggregation
will report lower values of health spending income elasticity.
- country/ region analyzed by the primary study. Many papers looking at
the aggregate health expenditure drivers have focused on OECD countries. There are
however some studies in our database that use African countries, Middle Eastern or
Economic Cooperation Organization countries as the base of their analysis. Our MRA
will include a dummy variable of the area being studied, in order to see whether it
influences in any way the reported income elasticities of health spending. We expect
a positive estimated coefficient, which would suggest that analysis of OECD countries
delivers higher income elasticities and reports that health care behaves as a luxury good
in developed countries .
- alternative ways in which health expenditure is measured. The majority
of studies focused on uncovering the drivers of total health costs has been measuring
these costs in levels. New research suggests that attention should be given not only to
the level of health expenditure, but also to the drivers of health spending growth rates.
Some evidence of β-convergence in health spending has been found, where countries
that initially have a low expenditure record increased growth in health spending, while
those countries with an initial level of health spending already high exhibit a lower
growth trend (Barros 1998). We include a dummy variable for the way in which health
spending is measured, in an attempt to identify whether levels or growth rates of health
expenditure influence the magnitude of the reported income elasticity.
- type of data used. Our MRA will control also for the data set being employed by
the primary study. The purpose is to see whether employing cross-sectional, time-series
or panel data yields different estimates of income elasticity. Employing panel data is
expected to generate lower income elasticity estimates.
- estimation technique employed. Different estimation methods have been used
in the literature of the determinants of HCE expenditure, from simple OLS to WLS,
GLS or cointegration regression using dynamic OLS, CCEMG estimators, ECM or
FMOLS estimators. The multivariate MRA will control for the method employed in the
primary studies and quantify how the pick of different estimatation techniques affects
the reported outcomes.
- year of publication of study. The purpose of controlling for the year of pub-
lication of a study is to observe whether reported values of income elasticity of HE
are different with the passing of time and whether there exists a cyclical trend in the
research of drivers of health care expenditure. For this purpose, we also include in the
analysis the square value of the study’s year of publication. If these two variables prove
jointly significant and the relationship presents a concave shape, then the ”economics
research cycle hypothesis” can be confirmed (Havránek 2012, p.21). This hypothesis as-
sumes that initial results in a field of research tend to be confirmed by following studies,
but with the pass of time, opposite results become preferable, since they bring a new
argument to the table and keep the research alive (Goldfarb 1995 in Havránek 2012).
- moderator variables included in the primary study. Our multivariate MRA
will include a number of dummy variables that will account whether income is the sole
explanatory variable used in the primary study; whether the primary research controls
for institutional variables (type of health care system; physicians working as gatekeep-
ers; no. of physicians per 1,000 people; degree of decentralization of health care system
etc.) and whether the primary study controls of medical technology advancements (by
including among its explanatory variables various proxies for medical technology: med-
ical R&D, time-trend, no. of medical procedures/ 1000 people, etc). The purpose is
to reveal whether employing models with different explanatory variables causes het-
erogeneity in reported effects of income on health care expenditure. We expect that,
generally, the inclusion of other independent variables apart from income will result in
lower income elasticity values.
- conversion method of health care expenditure. A number of studies in the
literature draw attention on how different ways of converting health care expenditure
in international comparisons can affect one study’s outcomes. Studies have been em-
ploying PPPs, exchange rates, CPI or GDP deflator. Our MRA will control for these
different conversion ways and see whether they contribute to the heterogeneity of income
elasticities of health spending.
- number of years covered by primary study data. Research performed over
a short period a time might provide unreliable results. We have decided to control for





SE standard error of reported income elasticity 0.164 (0.16)
pubyear year of publication of study(base year=1977) 24.36(7.02)
sqpubyear square of study’s year of publication
years number of years covered by primary data 19.60(15.59)
only inc =1 if income the sole explanatory variable of primary study 62
growth =1 if health expenditure is measured in growth rates 17
panel =1 if estimate comes from panel data 114
cross =1 if estimate comes from cross-sectional data 80
timeseries =1 if estimate comes from time-series data 40
OECD =1 if estimate comes from OECD data 212
institut =1 if model includes institutional variables 53
technology =1 if model includes proxiesfor technology advancements 38
OLS =1 if OLS estimation used 131
other estimation = 1 if other estimation technique employed (WLS, GLS, ML) 42
cointeg =1 if cointegrating regression used 64
PPP = 1 if Purchasing Power Parity used to convert health expenditure 177
internat =1 if international comparison of health expenditure performed 192
Note: For SE, pubyear and years, the reported summary statistic is the mean and the standard deviation.
For the dummy variables, we report the number of observations for which the dummy variable is equal to 1.
this detail as well and record its influence on our meta-dependent variable.
Table 4.3 provides an overview of all meta-independent variables employed in our
multivariate MRA, alongside some summary statistics.
Roughly 90 % of the studies in the meta-dataset analyze OECD countries. Approx-
imately 56% of the primary research employs OLS techniques, while 75% of the studies
performing international comparisons of health spending use PPP for converting the
different income and health care expenditure values into a common metric. On average,
the number of years covered by the data of a primary study is 20 years, with a mini-
mum of one year for cross-sectional studies and a maximum of 44 years. About half of
the literature (48.5%) employs panel data, while the other half uses cross-sectional or
time-series data.
The correlation matrix among all independent variables can be found in Appendix
C. There are few strong correlations and many of them are expected. The dummy
variable accounting for the use of cross-sectional data by a primary study appears highly
correlated with the number of years of the study’s data (r = −0.81) and with the
dummy accounting for a primary study that uses panel data (r = −0.70). Since the
variables ”cross’, ”panel” and ” timeseries” are categorical variables referring to the
same characteristic of a primary study, one would have to be disregarded from our
multiple MRA model, and since ”panel” and ”timeseries” variables do not present any
high correlations with other variables, the meta-independent variable ”cross” will be
the one left out of the model.
The same principle was applied for the ”cointeg” variable, which signals whether a
primary study uses cointegration regression as its estimation technique. ”OLS”, ”coin-
teg” and ”other estimation” are categorical variables, and from the three of them,
”cointeg” presents a high positive correlation with both ”years” variable (r = 0.60) and
”OLS” variable (r = −0.67), as expected. Since ”OLS” and ”other estimation” have
lower correlations with the rest of the meta-independent variables, ”cointeg” will not
be included in the multiple MRA model.
The correlation relations among the other independent variables do not indicate very
strong relations that could represent a threat for our multiple MRA model’s reliability.
It would be worth noticing the positive correlation between ”PPP” and ”pubyear” vari-
ables (r=0.43), indicating that the use of exchange rates as conversion method between
international health expenditures is a rather obsolete method, and newer research tends
to use PPP instead. The publication year of a study is also relatively highly correlated
in a negative direction with the variable accounting for a study using international
data (r=−0.38). This suggests that, with the pass of time, studies became more aware
of the difficulties and biases the comparisons between countries with different health
care systems and underlying conditions could bring, and prefer to focus on analysis of
national-level data. Finally, an interesting observation is related to the correlation be-
tween the standard error of health spending’s income elasticity estimate and the ”cross”
and ”panel” variables. The magnitude of the correlation relations is roughly the same,
but in opposite direction, suggesting that the use of cross sectional data generates higher
standard errors (r= 0.20), while the use of panel data reports estimates with lower stan-
dard errors (r=−0.20) and therefore higher precision.
Chapter 5
Results
5.1 Testing for publication bias
The identification of causes of heterogeneity in reported health spending income elas-
ticity values started with a check for publication bias. Due to publication selection,
reported estimates can be heavily distorted, and estimating the true effect without con-
sidering the possibility that published results might have been purposely picked would
still generate biased estimates of the true income elasticity.
The visual inspection of the income elasticity values plotted against their preci-
sion(Figure 4.2) revealed the presence of, what seemed, not very strong but still present,
publication bias. The simple FAT-PET MRA mentioned in equation 3.7 was further
estimated, to formally test for publication bias. In order to avoid the risk of het-
eroskedasticity, each estimate was weighted by the inverse of its squared precision. Var-
ious estimation techniques have been used, so as to ensure the robustness of our results.
The outcomes of the simple MRA can be viewed in Table 5.1.
The first column corresponds to the simple WLS model. The model reports that
publication bias does exist (β̂1 = −1.29), at a significance level of 5%. It also suggests,
with 99% confidence, that there exists a true effect of income on health spending situated
above unity value.
Due to the possible dependence between estimates collected from the same study, we
continue our analysis with a cluster robust version of the WLS model, where observations
are clusterd at study level. As it is expected, the coefficients’ magnitudes remain the
same, but the standard errors change and render the intercept insignificant, which means
that we can no longer reject the null hypothesis that there is no publication selection
among our collected elasticities. The intercept is still significant at 1% level.
In order to capture all aspects of our dataset, we further estimate a number of
multilevel models. Since there might be a consistent within study variance, a fixed-
effects model was estimated to account for this variance. The results are presented in
column 3. In this case, the slope parameter has a negative sign, but continues being
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Table 5.1: Simple MRA results
(1) (2) (3) (4) (5) (6) (7)
WLS WLS cluster robust FEML REML Median ME PEESE
β̂1(pub.bias) -1.291
∗∗
-1.291 -0.280 0.115 -1.967
∗∗∗
0.0858
(0.529) (1.345) (0.417) (0.248) (0.640) (0.247)
β̂1(PEESE test) -1.443
(0.947)














(0.0297) (0.0299) (0.0688) (0.0919) (0.0472) (0.0951) (0.0290)
Observations 220 220 220 220 220 220 220






p < 0.01. Column 1 = weighted least squares model, where variables
have been weighted by inverse of squared precision. Column 2 = cluster robust standard errors, with clusters at study level.
Column 3 = fixed effects multilevel model. Column 4 = random-effects multilevel model. Column 5 = estimation at median level.
Column 6 = mixed effects multilevel model. Column 7 = independent variable is no longer the standard error, but the variance.
insignificant (β̂1 = −0.28). The significance of β̂1 at a 1.092 value suggests there exists
a true effect of income elasticity, as might be expected since publication bias has not
been proved in this case, and that according to this value, health care lies in the luxury
good category.
Although not recommended in MRA analysis, we estimated a random-effects model
as well (column 4). As might already be known, the basic assumption of a random
effects-model is that the unobserved values of its dependent variable are independent
of the explanatory variables. In our case, we are testing for publication bias because
in fact we suspect the reported income elasticities of aggregate health expenditure are
correlated with their standard error, and implicitly with the inverse of the standard
error, which then violates the RE assumption. Due to this reason, S & D (2012) advocate
the use of fixed-effects models in MRA, whose assumptions are respected in a higher
percentage. After estimating both models, the Hausman test was implemented, in order
to reveal which of these two models is preferred. With a p-value of 0.0006, the Hausman
test clearly rejects the random-effects model, which proves the recommendations of the
MRA literature.
The multilevel mixed effects estimation (column 6), which can successfully be used
in the case of clustered observations of a single variable and unbalanced data, and is
actually recommended in MRA analysis (S & D 2012, p.100), delivers a still insignifi-
cant slope parameter, strengthening the idea that the literature evaluating the income
elasticity of aggregate health does not suffer majorly from publication bias.
We also estimated two models that take into consideration the variables’ measure of
central tendency. The results of the model using the median values of each of the two
variables included in the simple MRA are reported in column 5 and they offer a different
view than previous estimations. Since the median is a measure of central tendency, it
is not as seriously affected by outliers as the mean. In this model, the publication bias
indicator becomes highly significant, meaning that the null hypothesis of no publication
bias can be rejected at 1 % confidence level. Its negative sign would suggest that
preference for publication is given to those studies reporting income elasticity values
of health expenditure below unity. In what regards the true income elasticity β̂1, it
exhibits a value close to unity, at 1.04.
A final attempt to tackle the problem of the likely dependence among our effect
sizes was performed by running an MRA on the weighted averages of each study’s es-
timate and their standard errors (results not reported in Table 5.1). In this case, each
study provides a single averaged effect size of all its estimates. Therefore, the number
of observations of the MRA is equal to the number of studies (54, compared to 220
as in the previous models). Each estimate of income elasticity has been weighted by
the sample size. Afterwards, the average effect size for each study was computed. The
same strategy was adopted for calculating average standard errors and t-values. The
estimation generated an insignificant β̂1 = −0.070 and a β̂0 = 1.12 significant at 10%.
We cannot reject the null of no publication bias once again, while the true effect value is
significant and for the first time lies slightly below unity (β̂1=0.966). While employing
the average estimate of each study is considered to offer a more realistic evaluation of
the MRA statistical significance (S &D 2012, p.72), it should not be overlooked that the
much smaller number of observations employed in this case gives the model less degrees
of freedom and makes it unable to capture the entire bias resulted from the collection
of different estimates from a same study, even though they have been weighted by the
sample size. This could explain, if even only a part, the newly found below-unity true
income elasticity value.
We have presented various models used to test for the existence of publication se-
lection in the literature on the influence of income per capita on aggregate health care
expenditure. The various results seem to indicate, in general terms, that publication
bias is not a serious problem. Many of the employed specifications did not find sig-
nificant values for the slope parameter. Those that have, found negative values of β̂1,
which would indicate that reported estimates of income elasticity of aggregate health
care expenditure are skewed towards values lower than unity. This suggests a tendency
in the literature towards publishing those studies which find that health care behaves
as a necessity rather than a luxury good. If we consider the suggestion of S &D (2012,
p.159) that larger values of β̂1 are indicators of larger publication selection, then the idea
of under-reporting elasticities higher than one is mildly supported by the magnitudes
of β̂1, which are no bigger than the value of -1.96.
Most evidence drives the conclusion towards the idea that the hypothesis of no
publication bias cannot be rejected. The FE-cluster robust model and ME model, by
employing all observations, providing robust standard errors and taking into consider-
ation the unbalanced nature of data, could also be considered reliable, and they both
point at estimates not significantly biased by publication selection.
In what regards the existence of a true estimate of income elasticity, it could be
said that a general consensus has been uncovered. All the models found significant
β̂0 estimates, which in all cases were above unity. This finding points to a true effect
of income on aggregate health care spending, suggesting at the same time that health
expenditure increases at a slightly faster rate than income does, and thus, health care can
be labeled a luxury good. The result comes logically, since when there is no significant
publication bias, the results reported by the literature can actually be trusted and
averaging them should provide a trustworthy measure of the true income elasticity.
Since the PET test rejected the null hypothesis, which assumed that there is no true
effect of income on health expenditure, we also estimated β0 using the PEESE test,
which is believed to offer a better estimation of the corrected true effect. It should be
remembered that the PEESE model – equation 3.9 – considers as independent variable
in the regression not the standard error of the estimates, but their variance, and that
the model has no intercept. Results of the PEESE test are presented in column 7. The
true effect estimate stands at 1.12 value, thus supporting the idea of health care being
a luxury good.
All in all, it could be said that publication bias does not represent a serious concern
for the literature analyzing the effect of per capita income on health spending. The weak
evidence that was found of its presence suggests a mild preference for under-reporting
elasticities above unity. This would point to some efforts made towards convincing
governments to take more responsibility in ensuring that all citizens benefit from health
services, since with an income elasticity below one, health care becomes a necessity. In
fact, as results of our PEESE test suggest, health care is more a luxury good and, as
Newhouse (1977, p.123) emphasized, its main purpose might be directed rather towards
”caring than curing”. The finding also supports Kotzian’s (2003, p.24) discovery that
individuals tend to evaluate and be satisfied with health care systems performance based
on their ’caring’ ability, while the ’curing’ function is often taken for granted.
Although no strong evidence for publication bias could be discovered, there is still
heterogeneity among the reported health care spending income elasticities which needs
to be explained. We further look into more detail at the possible factors causing this
heterogeneity by employing the multivariate MRA model.
5.2 Explaining heterogeneity. Multiple MRA
The results of the G-to-S modeling rendered significant 6 independent variables, that
passed the robustness check and maintained their significance across different specifi-
cations. However, since the general-to-specific approach is rather frowned upon in the
econometric world, we present the results of our parsimonious strategy only in Appendix
D. As the main approach towards the multiple MRA, we adopt an opposite direction,
starting from the bivariate FAT-PET model and gradually enriching the model with
more independent variables.
Although some newly added variables prove insignificant, the joint significance test-
ing we perform at each step does not show at any time that the model becomes jointly
insignificant. Thus, our final specification includes all 14 independent variables. It can
be observed that the variable ”cross”, which accounts for cross-sectional data having
been used in the primary studies, alongside the variable expressing if cointegration was
the estimation technique used in the primary studies, were not included in the multiple
MRA, due to high correlations with other independent variables.
The simple WLS MRA (column 1 of Table 5.2)is able to explain 48 % of the hetero-
geneity in reported income elasticity values. The Breusch-Pagan test does not indicate
any signs of heteroskedasticity among the variables (chi214 = 394.34, p-value < 0.0001).
Ramsey’s RESET test rejects the null hypothesis that the model has no omitted vari-
ables ( F3,199 = 3.03,p-value = 0.03), which brings questions about other variables not
included in our model, which could be able to explain the heterogeneity in collected
elasticity values. We try to adress this issue by employing the mixed effects multilevel
model in column 5.
The first estimation of the multiple MRA model reveals a number of 7 significant
variables. At a 1% significance level, the results show that studies which analyze OECD
countries report income elasticities of aggregate health spending higher with 0.50% than
analysis focusing on non-OECD nations.
Furthermore, accounting for institutional factors in one’s research will decrease the
values of the income elasticity obtained by 0.45 %. Including proxies for medical tech-
nology advancements in the primary model will also give lower income elasticities than
research which ignores these factors, the decrease being of 0.20%.
Using PPPs instead of exchange rates for conversion of health expenditures of dif-
ferent countries will generate income elasticities higher with 0.31%. Interestingly, the
literature seems to exhibit a time trend as well. Studies having been published more re-
cently, appear to report lower income elasticities of aggregate health expenditure. More
exactly, newer research will report income elasticity values 0.01% lower than results pro-
vided by papers published a year before. Although the magnitude of the change brought
by time is not very big, it is still an interesting fact to notice that time seems to have
an influence on the results found in the literature of health care spending determinants.
Significant at 5% level, the variable accounting for the use of time series by a pri-
mary study reveals that reported elasticities will be 0.26% higher than those of studies
employing cross-sectional data. The result brings about questions, since cross-sectional
data is mainly used by initial studies in the area, and they are the ones which normally
report the highest health costs income elasticity values. The reliability of the time series
variable is proven doubtful by following specification, as although it remains significant,
Table 5.2: Multiple MRA results
(1) (2) (3) (4) (5)
WLS WLS WLS cluster robust ME PEESE
S.E -0.355 0.436 -0.355 0.0930
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it experiences major shifts in the coefficient’s magnitude (for example, in the ME model,
the coefficient’s magnitude is 0.691, while in the WLS specification is 0.266). The initial
set of results also uncovers that research on the effect of per capita income on health
care costs which is done at an international level, using data from different countries,
generates higher outcomes by 0.07% than those studies employing national-level data.
However, the significance of this variables is low, with a p-value of 0.071.
Column 2 tests the hypothesis of the ”economics research cycle”. For this, the square
of the primary study’s year of publication is added to the model. This newly added
variable, although is has a very low magnitude (coefficient = −0.002), is significant at
1% level. In addition, the variable accounting for the study’s publication year remains
significant and changes sign, exhibiting a coefficient of 0.08. Thus, we cannot reject the
hypothesis that the literature on the determinants of health care expenditure follows
an ”economics research cycle”. This signifies that there seem to be trends in reported
research to favor a groundbreaking finding for a period of time, but after some years
give preference to outcomes which contradict the initial findings and become the new
trend in research.
Although heteroskedasticity was not signaled as a problem for the WLS model, we
further estimated the model employing cluster robust standard errors, with estimates
clustered at the study level (column 3), in order to check for other problems that could
bias our results, such as autocorrelation. The magnitude of the coefficients is unchanged,
as normal, but some independent variables lose their significance. More specifically, the
variables accounting for international data and time series being used in the primary
studies lose their significance. Furthermore, the publication year of a study seems not to
exert any influence on the reported health costs income elasticities. The intercept keeps
its significance, suggesting the existence of a true elasticity value, while the coefficient
of the standard error remains insignificant, as in the previous specifications, offering no
evidence for publication bias.
As a further robustness check, the regression model is estimated by ways of multilevel
mixed-effects, following the recommendations of various scholars (Bateman & Jones
2003, Stanley & Doucouliagos 2012), in order to account for the dependence among
estimates and correct the standard errors adequately. Only 3 independent variables,
alongside the intercept, are significant in this case. The variable which codes studies
that analyze OECD countries keeps exerting a positive influence on reported income
elasticities, exhibiting a coefficient of 0.36. The true effect remains significant, with an
increased value than in previously estimated models (β̂0 = 1.03), which would bring
health care closer to the luxury good category, although its income elasticity so close to
unity does not offer very strong support. Papers which include institutional variables
and proxies accounting for medical technological developments tend to generate lower
income elasticities of health care spending, while the publication year of a study is still
insignificant.
Lastly, column 6 presents the results of the PEESE model, employed to get the
better estimates model of our true effect. When using the square standard error as an
independent variable, instead of the simple standard error as was the case in the previous
columns, the true income elasticity is estimated at 0.721, with a 99 % confidence. The
slope of the squared standard error, which is the sign for publication bias, is insignificant
(p- value = −.89), meaning that publication selection is not present in the literature in
great measure.
5.2.1 The ”best practice” estimate
Having uncovered some of the causes underlying the heterogeneity in reported income
elasticities of health care spending, we can further estimate the true income elasticity,
dependent on the study’s components. Whether a study uses OLS or cointegration
techniques, cross sectional or panel data or observations spanning over 5 or 20 years are
details that influence research outcomes, and we can asses in what measure. Further-
more, since we already know some of the research’s characteristics that have an effect
on its outcomes, we can consider as“ideal study” the ones which take into consideration
all variables found significant by the multiple MRA.
In an initial phase, no preference or conditions were set over what an ”ideal study”
should look like. Thus, the independent variables were all considered at their sample
means. The estimated income elasticity for this case resulted to be significant at a 1 %
level, with a value of 0.92 and a 95 % confidence interval (0.73, 1.10). Compared to the
average effect size computed in Table 4.2, this result is very similar to the REE average.
Next, we estimate the true underlying income elasticity by placing conditions on the
variables found significant across the multiple specifications in Table 5.2. We thus set
the dummy variables ”OECD”, ”institut” and ”tech” at their maximum sample value,
which is 1. This means that we compute the estimate generated by those studies that
analyze OECD countries and account for institutional and medical technical advance-
ments. The rest of the variables are left at their sample mean value. The resulted ”best
practice” estimate is significant at 1 % level, with a value of 0.51 and a 95 % confidence
interval of (0.16, 0.85). This would mean that studies believed to include all factors that
might influence reported income elasticites of health spending and thus being the“best
practice” studies, generate outcomes which point at health care being a necessity, and
not a luxury good. This finding is rather striking if we compare it to the average effect
size, which is more vague about the true nature of health care, having values close to
unity.
If the assumptions change and we also put a condition on the“time series” and “PPP”
variables, which were found significant across most of our multiple MRA specifications,
then the estimate of the true income elasticity rises to 0.67, significant at 1% level with
a 95% confidence interval of (0.26, 1.08). Once again, health care can be classified as
a necessity, with an 10% increase in income levels (measured as GDP/capita in most
studies) bringing about an increase of 7% in aggregate health spending.
However, the “best practice” definition is rather a subjective one and most certainly
other variables or structural factors of research should be included among the assump-
tions, as proof standing the R2 of the multiple MRA, which is able to explain only about
48% of the heterogeneity in reported elasticities.
Chapter 6
Discussion and conclusion
The present study has tried to uncover the true magnitude of the relation between per
capita income and aggregate health care expenditure. Previous research in the field
has not been able to reach a general consensus and during time there have been voices
stating that health care is a necessity good, while others advocated for rather labeling
it as a luxury one.
Our research reveals that the truth lies somewhere in the middle and that the MRA
analysis of the literature is sensitive to the estimation method used. We found very little
evidence of publication bias, and the one that was discovered indicates that values above
unity of the income’s effect on health expenditure tend to be slightly under-reported or
under-published, and studies which find that health care is a necessity are given pref-
erence for publication. In other words, the distribution of income elasticities is skewed
to the left. This idea is also supported by the visual representation of our observations,
which resembles a slightly asymmetrical funnel plot. The conclusion makes sense in the
context of simple MRA, as reported“true” income elasticity of health spending stands
at values above unity, which is higher than the REE averaged value. The difference
between the two is a result of negative publication bias, which instead of reporting all
income elasticity estimates, picks smaller ones, causing the averaged elasticity reported
by the literature to be smaller than the true one. Once more variables are added to the
MRA model, the coefficient indicating publication bias becomes insignificant across all
specifications, and the null hypothesis of no publication bias cannot be rejected. How-
ever, one must not neglect the fact that not being able to reject the null hypothesis does
not automatically mean there is absolutely no publication bias in the literature. We
thus conclude that while publication bias is not a serious concern for the literature, we
suspect it exerts an influence on outcomes in a negative direction. Further research, in-
cluding more observations, possibly from the studies we had to discard from our dataset
due to various reasons (see Appendix B), could bring stronger evidence.
Our research finds strong support for the existence of certain study characteristics
which have an influence on the magnitude of reported health spending income elasticity.
58
More specifically, papers which include among their independent variables a proxy that
accounts for institutional characteristics of the health care systems under analyze, e.g.
number of physicians per 1,000 persons, degree of centralization, social insurance cov-
erage etc., will generate lower income elasticity estimates. The same applies for those
studies that account for the technological developments in the medical field, by intro-
ducing in their regression model either a time-trend, a measure of medical R & D or
other appropriate proxies. The type of data used by a study also exerts an influence on
its resulting income elasticity, with studies employing time series data reporting higher
income elasticity values. Moreover, we find that research focused on analyzing OECD
countries generates higher elasticity values.
These findings have a significant importance for future research, as they point at
a number of components that should be included in a study, in order to get closer to
the“best practice” research design. Thus, future studies on the determinants of health
care expenditure should account for institutional and technological advancements in the
medical field and include a measure of these among the independent variables. They
should also consider employing time-series or panel data, instead of cross-sectional one.
Moreover, the use of PPP instead of exchange rates when carrying out the conversion
among health expenditure levels expressed in various national currencies also seems to
be worthy of consideration, since the “PPP” variable’s coefficient managed to pass all
robustness checks, being insignificant only in the mixed-effects multilevel model.
Although we expected the type of estimation technique employed by a research
(OLS or cointegration) to have a significant influence on reported income elasticities,
this assumption has not been proven by the MRA outcomes. Instead, the hypothesis
of an ”economic research cycle” was confirmed, meaning that the literature on the
determinants of health care expenditure follows certain cyclical trends when reporting
its results. Therefore, while we did not find that the literature suffers from considerable
publication bias, there still exists another influence that affects reported outcomes, and
this bias is not due to publishers, but rather to authors, who try to comply with the
trends of research of the time. This would imply that the lower income elasticities
which started being reported in the last decade are not only a result of methodological
advancements, but also a phase in the research cycle, corresponding to refuting previous
results and adopting a skeptical view. The trends in research which were identified in
section 1.1 offer support to the confirmed ”economic research cycle hypothesis”.
In what regards the true income elasticity size, the multiple MRA finds across differ-
ent specification that a true effect of income on aggregate health spending does exist, but
its value is fluctuating: a WLS cluster robust model suggests that the income elasticity
is below unity level (0.896), while the ME estimate is slightly above one (1.064), being
more in line with the results provided by the simple MRA. We would conclude that if
we consider the weak evidence for publication bias, then the REE average elasticity size
(0.921) could, in general lines, be a reliable representation of the true income elasticity.
Slightly higher values of the true effect could be considered as well, corresponding to the
situation of publication bias working towards the publishing of under-inflated income
elasticities. Then, the results provided by the ME multilevel model (1.032), which also
accounts for unobserved between-studies heterogeneity and the unbalanced nature of
our data, would represent a reliable expression of the true income’s elasticity value.
This results, however, while statistically significant, do not seem to provide an answer
to the initial question. With an income elasticity close to unity, health care cannot be
named neither a luxury good, nor a necessity. Its fluctuating true underlying values
would seem to offer support to Getzen’s similar claims, who mentions that health care
cannot be put into either category of goods, but it is both a luxury and a necessity,
as income elasticity varies with the level of analysis (Getzen 2000). He reveals that at
an individual level, health care stands in the necessary good category, while at higher
aggregated level, i.e. national, it behaves as a luxury good. This is an interesting
hypothesis to test by future MRA research. Estimates observed at individual level could
be included among the meta-observations, although it is open to discussion whether
outcomes measured at individual level could be compared with those computed at a
national level, since the decisions regarding the level of health care spending are based
on widely different factors at the two levels.
Another interesting topic for further research would be to check whether and how dif-
ferent political forces influence reported estimates of income elasticity. Our hypothesis
could be tested by upcoming research by including an independent variable in the mul-
tiple MRA model which accounts for left-wing or right-wing governance and determines
whether it has any influence on health spending’s income elasticity. This suggestion
arises from the political considerations attached to the categorization of health care as
a necessity or luxury. It would be expected that a left- wing governance, which pro-
motes equal access to health for all citizens, would push towards results that present
health care as a necessity. On the other side, right-wing parties in power would prefer
empirical evidence of health care being a luxury good, which would then allow market
forces to intervene and pass more of the health provision and funding to the private
sector.
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López-Casasnovas, G.& M. Saez (2007): “A Multilevel Analysis on the Determinants
of Regional Health Care Expenditure: A Note.” The European Journal of Health Eco-
nomics: HEPAC: Health Economics in Prevention and Care 8 (1): pp. 59-65.
Martin, J. J. M., M. P. Lopez del Amo Gonzalez, & M. D. Cano Garcia (2011): “Review
of the Literature on the Determinants of Healthcare Expenditure.” Applied Economics
43 (1): pp. 19-46.
McCoskey, S. K. & T. M. Selden (1998): “Health Care Expenditures and GDP: Panel
Data Unit Root Test Results.” Journal of Health Economics 17 (3): pp. 369-76.
Mehrara, A. A. F. & A. R. Fazaeli (2009): “The Relationship between Health Expendi-
tures and Economic Growth in Middle East & North Africa (MENA) Countries.”Faslname-
Modiraite Salamat 35 (12): pp. 49-59.
Milne, R. & H. Molana (1991): “On the Effect of Income and Relative Price on Demand
for Health Care: EC Evidence.” Applied Economics 23 (7): pp. 1221-26.
Mosca, I. (2007): “Decentralization as a Determinant of Health Care Expenditure:
Empirical Analysis for OECD Countries.” Applied Economics Letters 14 (7).
Murillo, C., C. Piatecki,& M. Saez (1993): “Health Care Expenditure and Income
in Europe.” Health Economics 2 (2).
Murthy, N. R. & A. Okunade (2000): “Managed Care, Deficit Financing, and Aggregate
Health Care Expenditure in the United States: A Cointegration Analysis.” Health Care
Management Science 3 (4).
Murthy, V. N. R. & V. Ukpolo (1994): “Aggregate Health Care Expenditure in the
United States: Evidence from Cointegration Tests.” Applied Economics 26 (8): 797.
Murthy, V. N. R. & A. A. Okunade (2009): “The Core Determinants of Health Ex-
penditure in the African Context: Some Econometric Evidence for Policy.” Health
Policy 91 (1): pp. 57-62.
Murthy, V. N. R. (1992): “Conversion Factor Instability in International Comparisons
of Health Care Expenditure: Some Econometric Comments.” Journal of Health Eco-
nomics 11 (2): pp. 183-87.
Newhouse, J. P. (1977): ”Medical-Care Expenditure: A Cross-National Survey.“ The
Journal of Human Resources 12 (1): pp. 115-25.
O’ Connell, J. M. (1996): “The Relationship between Health Expenditures and the
Age Structure of the Population in OECD Countries.” Health Economics 5 (6).
O’Neill, C., L. Groom, A. J. Avery, D. Boot, & K. Thornhill (2000): “Age and Prox-
imity to Death as Predictors of GP Care Costs: Results from a Study of Nursing Home
Patients.” Health Economics 9 (8): pp. 733-38.
Okunade, A. A. (2005): “Analysis and Implications of the Determinants of Healthcare
Expenditure in African Countries.” Health Care Management Science 8 (4): pp. 267-76.
Okunade, A. A. & M. C. Karakus (2001): “Unit Root and Cointegration Tests: Time-
series versus Panel Estimates for International Health Expenditure Models.” Applied
Economics 33 (9).
Okunade, A.A & V. N.R. Murthy (2002): “Technology as a ’major driver’ of health
care costs: A cointegration analysis of the Newhouse conjecture.” Journal of Health
Economics 21 (1): pp. 147-59.
Okunade, A., M. Karakus, & C. Okeke (2004): “Determinants of Health Expenditure
Growth of the OECD Countries: Jackknife Resampling Plan Estimates.” Health Care
Management Science 7 (3).
Pagan, A. (1987): “Three econometric methodologies: a critical appraisal.” Journal
of Economic Surveys 1 (1-2): pp. 3-23.
Pammolli, F., M. Riccaboni, & L. Magazzini (2012): “The Sustainability of European
Health Care Systems: Beyond Income and Aging.” The European Journal of Health
Economics: HEPAC: Health Economics in Prevention and Care 13 (5): pp. 623-34.
Parkin, D., A. McGuire, & B. Yule (1987): “Aggregate Health Care Expenditures and
National Income: Is Health Care a Luxury Good?” Journal of Health Economics 6 (2):
pp. 109-27.
Phillips, J. M. & E. P. Goss (1995): “The Effect of State and Local Taxes on Eco-
nomic Development: A Meta-Analysis.” Southern Economic Journal 62 (2): 320.
Phillips, P. C. B. (1986): “Understanding Spurious Regressions in Econometrics.”
Cowles Foundation Discussion Paper 757. Cowles Foundation for Research in Eco-
nomics, Yale University.
Roberts, J. (1999): “Sensitivity of Elasticity Estimates for OECD Health Care Spend-
ing: Analysis of a Dynamic Heterogeneous Data Field.” Health Economics 8 (5).
Roberts, J. (2000): “Spurious Regression Problems in the Determinants of Health Care
Expenditure: A Comment on Hitiris (1997).” Applied Economics Letters 7 (5).
Rose, A. K., & T. D. Stanley (2005): “A Meta-Analysis of the Effect of Common
Currencies on International Trade.” Journal of Economic Surveys 19 (3): pp. 347-65.
Rudner, L. M., G.V. Glass, D. L. Evartt (2002): “Meta-Stat: A User’s Guide to the
Meta-Analysis of Meta-Stat.” ERIC Clearinghouse on Assessment and Evaluation De-
partment of Measurement, Statistics and Evaluation, University of Maryland. Available
online at: http://www.edres.org/meta. Last accessed [07 April 2014].
Samadi, A. & E. H. Rad (2013): “Determinants of Healthcare Expenditure in Eco-
nomic Cooperation Organization (ECO) Countries: Evidence from Panel Cointegration
Tests.”
Sen, A. (2005): “Is Health Care a Luxury? New Evidence from OECD Data.” In-
ternational Journal of Health Care Finance and Economics 5 (2): pp. 147-64.
Seshamani, M. & A. Gray (2004): “Ageing and Healthcare Expenditure: The Red
Herring Argument Revisited.” Health Economics 13 (4).
Stanley, T. D. (2001): “Wheat from Chaff: Meta-Analysis as Quantitative Literature
Review.” Journal of Economic Perspectives,pp 131-50.
Stanley, T. D. (2008): “Meta-Regression Methods for Detecting and Estimating Em-
pirical Effects in the Presence of Publication Selection.” Oxford Bulletin of Economics
and Statistics 70 (1): pp. 103-27.
Stanley, T. D., C. Doucouliagos, & S. B. Jarrell (2008): “Meta-Regression Analysis
as the Socio-Economics of Economics Research.” The Journal of Socio-Economics 37
(1): pp. 276-92.
Stanley, T. D. & H. Doucouliagos (2012): “Meta-Regression Analysis in Economics
and Business.” Vol. 5. Routledge.
Stanley, T. D. & S. B. Jarrell (1989): “Meta-Regression Analysis: A Quantitative
Method of Literature Surveys.” Journal of Economic Surveys 3 (2): pp. 161-70.
Stanley, T. D. & S. B. Jarrell (1998): “Gender Wage Discrimination Bias? A Meta-
Regression Analysis.” Journal of Human Resources, pp. 947-73.
Stearns, S. C. & E. C. Norton (2004): “Time to Include Time to Death? The Fu-
ture of Health Care Expenditure Predictions.” Health Economics 13 (4).
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General to specific modeling
(1) (2) (3) (4) (5) (6)
General WLS Preferred WLS WLS Cluster robust ME PEESE
se inc -0.355 -0.151 0.543 -0.151 0.129








































0.0610 0.0659 0.0978 0.0642




































































(0.180) (0.141) (0.257) (0.300) (0.410) (0.285)
Observations 220 220 220 220 220 220
R2 0.48 0.44 0.45 0.44 - 0.44






p < 0.01. Column 1 = general MRA model, all independent variables inclued;
weighted by inverse of squared precision. Column 2 = MRA model without previously resulted insignificant
variables. Column 3 = square of publication year variable introduced, to test for “economics research cycle
hypothesis”. Column 4 = cluster robust s.e.; cluster at study level. Column 5 = mixed-effects multilevel model.
Column 6 = the s.e of effect size replaced from the independent variables by its squared value.
